The present application is the US National Phase of PCT application IL2018/051350 to Hariton et al., filed Dec. 12, 2018, and entitled “PROSTHETIC VALVE AND DELIVERY TOOL THEREFOR,” which published as WO/2019/116369, and which claims priority from UK patent application GB 1720803.4, filed Dec. 13, 2017, and entitled “PROSTHETIC VALVE AND DELIVERY TOOL THEREFOR,” which is incorporated herein by reference.
Some applications of the present invention relate in general to percutaneous delivery of medical implants. More specifically, some applications of the present invention relate to prosthetic cardiac valves and techniques for implantation thereof.
Dilation of the annulus of a heart valve, such as that caused by ischemic heart disease, prevents the valve leaflets from fully coapting when the valve is closed. Regurgitation of blood from the ventricle into the atrium results in increased total stroke volume and decreased cardiac output, and ultimate weakening of the ventricle secondary to a volume overload and a pressure overload of the atrium.
An implant is provided having self-expanding portions, and non-self-expanding portions. The implant comprises a non-self-expanding tubular frame, which is balloon-expandable. The implant further comprises an outer frame, which comprises self-expanding flanges and a self-expanding upstream support portion. The self-expanding nature of the flanges and upstream support portion is provided by the outer frame being composed of a shape-memory alloy. The tubular frame is composed of a different material.
The outer frame is coupled to the tubular frame via pins that are composed of the same material as the tubular frame. One end of each pin is secured to the outer frame by a head of the pin. The other end of each pin is secured to the tubular frame by welding.
A delivery tool comprises a capsule that has two capsule-portions, one to constrain the flanges, and one to constrain the upstream support portion. The delivery tool further comprises a balloon, disposed within the tubular frame. At the implantation site, the flanges and upstream support portion are released from the capsule, and automatically deflect radially outwards. Subsequently, the balloon is inflated to radially expand the tubular frame.
The delivery tool further comprises projections, which are sufficiently rigid to axially push the tubular frame in order to press the flanges against tissue at the implantation site, but which are sufficiently flexible to not inhibit inflation of the balloon.
There is therefore provided, in accordance with an application of the present invention, apparatus for use at a native valve of a heart of a subject, the apparatus including:
a delivery tool, including:
the flanges are configured to automatically deflect radially outward upon exposure from the downstream capsule-portion,
the upstream support portion is configured to automatically deflect radially outward upon exposure from the upstream capsule-portion,
the tubular frame is configured to remain compressed around the balloon upon exposure of the tubular frame from the capsule, and
while the tubular frame is exposed from the capsule, inflation of the balloon plastically expands the tubular frame radially.
In an application, the prosthetic valve further includes one or more prosthetic valve leaflets disposed within the lumen and coupled to the tubular frame.
In an application, the tubular frame is disposed within the downstream capsule-portion of the capsule.
In an application, the tubular frame is composed of a material that is not a shape-memory alloy.
In an application, the tubular frame is composed of steel.
In an application, the tubular frame is composed of cobalt chrome.
In an application, the flanges are composed of a shape-memory alloy.
In an application, the flanges are composed of nickel titanium.
In an application, the balloon is fixed to the shaft.
In an application, both the upstream capsule-portion and the downstream capsule-portion are axially movable with respect to the shaft.
In an application:
a first capsule-portion selected from the group consisting of: the upstream capsule-portion and the downstream capsule-portion is attached to a tube, and is axially movable with respect to the shaft by the tube being slid over the shaft, and
a second capsule-portion selected from the group is attached to a rod, and is axially movable with respect to the shaft by the rod being slid though the shaft.
In an application, the upstream capsule-portion is retractable from over the upstream support portion by being moved away from the balloon, and the downstream capsule-portion is retractable from over the flanges by being moved away from the balloon.
In an application, the delivery tool further includes one or more elongate projections disposed within the downstream capsule-portion, each of the projections having (i) a tip-portion, and (ii) a base-portion, disposed deeper than the tip-portion into the downstream capsule-portion, the projections arranged circumferentially around the shaft-axis such that the tip-portions are arranged circumferentially around a downstream balloon-portion of the balloon, with the tip-portion of each projection being closer than its corresponding base-portion to the tubular frame.
In an application, each of the projections is sufficiently stiff that, when pushed against the tubular frame, it is capable of applying, to the tubular frame, an axial pushing force of at least 0.5 N.
In an application, each of the projections is sufficiently stiff that, when pushed against the tubular frame, the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 3 N.
In an application, when pushed against the tubular frame, the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 3 N and no more than 100 N.
In an application, when pushed against the tubular frame, the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 3 N and no more than 30 N.
In an application, when pushed against the tubular frame, the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 6 N and no more than 30 N.
In an application, when pushed against the tubular frame, the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 40 N and no more than 100 N.
In an application, when pushed against the tubular frame, the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 40 N and no more than 80 N.
In an application, when pushed against the tubular frame, the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 60 N and no more than 100 N.
In an application, the tubular frame is disposed within the downstream capsule-portion of the capsule, and the downstream capsule-portion is retractable from over the tubular frame and at least the tip-portions, exposing, from the downstream capsule-portion, the tubular frame and at least the tip-portions.
In an application, while the tubular frame and the tip-portions are exposed from the downstream capsule-portion, inflation of the balloon (i) radially expands the tubular frame, and (ii) deflects each of the projections radially outward within a respective radial plane on which the shaft-axis and the projection lie.
In an application, while the tubular frame and the tip-portions are exposed from the downstream capsule-portion, inflation of the balloon uniformly fills the lumen of the tubular frame.
In an application, a widest part of the balloon is disposed within the lumen.
In an application, each projection has a radial stiffness in its radial plane, and has a lateral stiffness in a respective lateral plane, the lateral stiffness being greater than the radial stiffness.
In an application:
the balloon has an upstream balloon-portion, a downstream balloon-portion, and a body balloon-portion therebetween,
the tubular frame is compressed around the body balloon-portion, and
while the tubular frame and the tip-portions are exposed from the downstream capsule-portion, inflation of the balloon (i) radially expands the tubular frame by pressing the body balloon-portion radially outward against the tubular frame, and (ii) deflects the projections radially outward by pressing the downstream balloon-portion radially outward against the projections.
In an application, the downstream balloon-portion of the balloon extends away from the tubular frame, and is tapered.
In an application, the upstream balloon-portion of the balloon extends away from the tubular frame, and is tapered.
In an application, the tip-portion of each of the projections abuts the tubular frame, and the apparatus is configured such that the tip-portion of each of the projections remains in contact with the tubular frame as the balloon is inflated.
In an application, a downstream end of the tubular frame defines a frame-circumference, the tip-portions define a projection-circumference, and while the tubular frame and the tip-portions are exposed from the downstream capsule-portion, inflation of the balloon increases the projection-circumference at the same rate as the balloon increases the frame-circumference.
In an application, the tip-portion of each of the projections abuts the tubular frame.
In an application, the projections are not attached to the tubular frame.
There is further provided, in accordance with an application of the present invention, apparatus for delivery of a prosthetic heart valve to an annulus of a native heart valve, the apparatus including:
a shaft, having a longitudinal shaft-axis;
an inflatable balloon, disposed at a distal end of the shaft; and
one or more projections extending distally from the shaft, such that the projections are arranged around a proximal portion of the balloon,
and:
inflation of the balloon causes radial expansion of the balloon, the radial expansion of the balloon applying a radial force to each of the projections, and
each of the projections is sufficiently radially flexible that the radial force deflects the projections radially outward.
In an application, for each of the projections:
the projection defines:
the projection has a radial stiffness, in its radial plane, and
the projection has a lateral stiffness, in its lateral plane, that is greater than the radial stiffness.
In an application, the apparatus further includes a tubular frame at the distal end of the shaft, the tubular frame defining a longitudinal lumen, and the balloon is disposed within the lumen.
In an application, each of the projections is sufficiently stiff that it is capable of applying, to the tubular frame, an axial pushing force of at least 0.5 N.
In an application, each of the projections is sufficiently stiff that the one or more projections are capable collectively of applying, to the tubular frame, an axial pushing force of at least 3 N.
In an application, the apparatus further includes one or more prosthetic valve leaflets disposed within the lumen and coupled to the tubular frame.
In an application, the balloon:
has a longitudinal balloon-axis, collinear with the longitudinal shaft-axis, the balloon-axis extending through the lumen,
has (i) a deflated state, and (ii) an inflated state in which the balloon has a widest part, and
is positioned with respect to the tubular frame such that the widest part is within the lumen.
In an application, the balloon, in its inflated state, uniformly fills the lumen.
In an application, in the inflated state of the balloon, the proximal portion of the balloon tapers proximally away from the tubular frame.
In an application, the balloon, in its inflated state, has a tapered distal portion that tapers distally away from the tubular frame.
In an application, the widest part of the balloon is disposed longitudinally between the proximal portion and the distal portion.
In an application, each of the projections has a tip-portion that abuts a proximal surface of the tubular frame.
In an application, the tip-portion of each of the projections is not attached to the tubular frame.
In an application, inflation of the balloon simultaneously increases (i) a radial distance between the tip-portion of one of the projections and the tip-portion of an opposite one of the projections, and (ii) a circumference of the tubular frame.
There is further provided, in accordance with an application of the present invention, apparatus for use in a heart of a subject, the apparatus including:
a tubular frame that circumscribes a longitudinal axis to define a lumen along the longitudinal axis;
a valve member, disposed within the lumen and coupled to the tubular frame;
an outer frame:
a pin:
the outer frame is composed of a shape-memory alloy,
the tubular frame and the pin are composed of a material that is not the shape-memory alloy,
the head is disposed against the outer frame, radially outward from the eyelet,
the shaft extends from the head through the eyelet to the tubular frame, and
the shaft is welded to the tubular frame.
In an application, the outer frame further includes an upstream support portion, shape-set to extend radially outward from the tubular frame.
In an application, the flange is shape-set to extend radially outward from the tubular frame.
In an application, the outer frame further includes an upstream support portion, upstream support portion is shape-set to extend radially outward from the tubular frame, and the flange is shape-set to extend radially outward from the tubular frame and toward the upstream support portion.
In an application:
the flange has a root-portion and a tip, and extends away from the tubular frame from the root-portion to the tip,
the eyelet is defined at the root-portion of the flange, and
the head is disposed against the root-portion of the flange, radially outward from the eyelet.
In an application, the eyelet is an outer eyelet, and the tubular frame defines an inner eyelet, the shaft extending through the inner eyelet.
In an application, the shape-memory alloy is nickel titanium.
In an application, the material is not a shape-memory material.
In an application, the material is steel.
In an application, the material is cobalt chrome.
In an application, the flange is one of a plurality of flanges, and the outer frame includes the plurality of flanges, and circumscribes the tubular frame.
In an application, the eyelet is one of a plurality of eyelets, and the outer frame defines the plurality of eyelets.
In an application, the flanges of the plurality of flanges are equal in number to the eyelets of the plurality of eyelets.
In an application, the eyelet is one of a plurality of eyelets, and the root-portion of each flange of the plurality of flanges defines a respective eyelet of the plurality of eyelets.
There is further provided, in accordance with an application of the present invention, a method for constructing a prosthetic heart valve, the method including:
from a tube of a shape-memory alloy, cutting an outer frame that includes a flange and defines an eyelet;
from a tube of a material that is not the shape-memory alloy, cutting a tubular frame that circumscribes a longitudinally axis to define a lumen along the longitudinal axis;
positioning the outer frame against the tubular frame, radially-outward from the tubular frame;
passing a shaft of a pin through the eyelet such that (i) the shaft of the eyelet extends to the tubular frame, and (ii) a head of the pin is disposed against the outer frame radially outward from the eyelet, the pin being composed of the material;
welding the shaft to the tubular frame;
lining at least part of the lumen with a lining; and
securing a plurality of prosthetic leaflets within the lumen.
In an application, the method further includes shape-setting the flange to extend radially outward.
In an application:
cutting the outer frame includes cutting the outer frame such that the flange has a root-portion and a tip, and defines the eyelet at the root-portion, and
passing the shaft of the pin through the eyelet such that the head of the pin is disposed against the outer frame radially outward from the eyelet, includes passing the shaft of the pin through the eyelet such that the head of the pin is disposed against the root-portion of the flange, radially outward from the eyelet.
In an application:
the eyelet is an outer eyelet, and cutting the tubular frame includes cutting the tubular frame such that the tubular frame defines an inner eyelet, and
the step of passing the shaft includes passing the shaft through the outer eyelet and through the inner eyelet, and
welding the shaft to the tubular frame includes welding the shaft to the tubular frame at the inner eyelet.
In an application, the shape-memory alloy is nickel titanium, and cutting the outer frame from the tube of the shape-memory alloy includes cutting the outer frame from a tube of nickel titanium.
In an application, the material is not a shape-memory material, and cutting the tubular frame includes cutting the tubular frame from the material that is not a shape-memory material.
In an application, the material is steel, and cutting the tubular frame from the tube of the material includes cutting the tubular frame from a tube of steel.
In an application, the material is cobalt chrome, and cutting the tubular frame from the tube of the material includes cutting the tubular frame from a tube of cobalt chrome.
In an application, cutting the outer frame includes cutting the outer frame that further includes an upstream support portion.
In an application, the method further includes shape-setting the upstream support portion to extend radially outward.
In an application:
the flange is one of a plurality of flanges,
cutting the outer frame includes cutting the outer frame such that the outer frame defines the plurality of flanges, and
positioning the outer frame includes positioning the outer frame such that the outer frame circumscribes the tubular frame.
In an application, the eyelet is one of a plurality of eyelets, and cutting the outer frame includes cutting the outer frame such that the outer frame defines the plurality of eyelets.
In an application, cutting the outer frame includes cutting the outer frame such that the outer frame has an equal number of flanges and eyelets.
There is further provided, in accordance with an application of the present invention, a method for use at a native valve of a heart of a subject, the method including:
advancing, to the heart, an implant that includes a tubular frame, the tubular frame disposed on a distal portion of a tool, the distal portion of the tool including:
pushing the projections distally against the tubular frame to apply a distal pushing force to the tubular frame; and
while maintaining contact between the projections and the tubular frame, inflating the balloon such that:
In an application, pushing the projections distally against the tubular frame comprises pushing the projections distally against the tubular frame such that the projections collectively apply a distal pushing force of at least 3 N to the tubular frame.
In an application, pushing the projections distally against the tubular frame comprises pushing the projections distally against the tubular frame such that the projections collectively apply a distal pushing force of at least 3 N and no more than 100 N.
In an application, pushing the projections distally against the tubular frame comprises pushing the projections distally against the tubular frame such that the projections collectively apply a distal pushing force of at least 3 N and no more than 30 N.
In an application, pushing the projections distally against the tubular frame comprises pushing the projections distally against the tubular frame such that the projections collectively apply a distal pushing force of at least 6 N and no more than 30 N.
In an application, pushing the projections distally against the tubular frame comprises pushing the projections distally against the tubular frame such that the projections collectively apply a distal pushing force of at least 40 N and no more than 100 N.
In an application, pushing the projections distally against the tubular frame comprises pushing the projections distally against the tubular frame such that the projections collectively apply a distal pushing force of at least 40 N and no more than 80 N.
In an application, pushing the projections distally against the tubular frame comprises pushing the projections distally against the tubular frame such that the projections collectively apply a distal pushing force of at least 60 N and no more than 100 N.
In an application:
the implant includes one or more self-expanding flanges,
the tool distal portion of the tool includes a capsule;
advancing the implant includes advancing the tubular frame while at least the flanges are disposed within, and constrained by, the capsule,
the method further includes, prior to pushing the projections distally, allowing the flanges to self-expand by exposing the flanges from the capsule, and
the step of pushing the projections distally against the tubular frame includes pushing the implant distally such that the flanges press against tissue of the native valve.
In an application, advancing the implant includes advancing the implant while the projections are disposed within the capsule, and exposing the flanges from the capsule includes retracting the capsule proximally with respect to the implant such that the flanges and the projections become exposed from the capsule.
There is further provided, in accordance with an application of the present invention, a method for use at a native valve of a heart of a subject, the method including:
advancing, to the heart:
exposing the flanges from the downstream capsule-portion such that the flanges automatically deflect radially outward;
subsequently, pressing the flanges against a downstream surface of the native valve by moving the implant in an upstream direction; and
while the flanges are in contact with the downstream surface, plastically expanding the tubular frame radially by inflating the balloon.
In an application, plastically expanding the tubular frame includes plastically expanding the tubular frame by radially by inflating the balloon while continuing to press the flanges against the downstream surface.
In an application, exposing the flanges from the downstream capsule-portion includes moving the downstream capsule-portion away from the upstream capsule-portion.
In an application, advancing the implant includes advancing the implant while the tubular frame is disposed within the downstream capsule-portion, and the method further includes exposing the tubular frame from the downstream capsule-portion.
In an application, exposing the tubular frame from the downstream capsule-portion includes exposing the tubular frame from the downstream capsule-portion prior to the step of pressing the flanges.
In an application, exposing the tubular frame from the downstream capsule-portion includes exposing the tubular frame entirely from the downstream capsule-portion without causing the tubular frame to expand.
In an application, the implant further includes a shape-memory upstream support portion, constrained within the upstream capsule-portion, and the method further includes, prior to expanding the tubular frame, exposing the upstream support portion from the upstream capsule-portion such that the upstream support portion automatically deflects radially outward.
In an application, moving the implant in the upstream direction includes moving the implant such that the upstream support portion, constrained within the upstream capsule portion, is disposed upstream of the native valve, and exposing the upstream support portion includes exposing the upstream support portion such that the upstream support portion automatically deflects radially outwards and contacts an upstream surface of the native valve.
In an application:
the implant is compressed around a body balloon-portion of the balloon,
the tool further includes one or more projections, each of the projections having a base-portion and a tip-portion,
the projections extend, from the shaft, over at least a downstream balloon-portion of the balloon toward the tubular frame, such that the tip-portion of each of the projections is closer than its corresponding base-portion to the tubular frame, and
pressing the flanges against the downstream surface by moving the implant in the upstream direction includes pushing the implant in the upstream direction by pushing the tip-portions against the tubular frame.
In an application, expanding the tubular frame includes inflating the balloon such that (i) the body balloon-portion radially expands the tubular frame by pressing radially outward against the tubular frame, and (ii) the downstream balloon-portion deflects the projections radially outward by pressing radially outward against the projections.
In an application, advancing the distal portion of the delivery tool includes advancing the distal portion of the delivery tool while the projections are disposed within the downstream capsule-portion, and the method further includes, prior to radially expanding the tubular frame, exposing at least the tips of the projections from the downstream capsule-portion.
In an application, exposing at least the tips of the projections from the downstream capsule-portion includes exposing at least the tips of the projections from the downstream capsule-portion prior to pressing the flanges against the downstream surface of the native valve.
There is further provided, in accordance with an application of the present invention, a method for use at a native valve of a heart of a subject, the method including:
advancing, to the heart:
subsequently, exposing the flanges from the capsule such that the flanges automatically deflect radially outward away from the tubular frame, and such that the array defines an inter-flange distance;
subsequently, by partially inflating the balloon to a partially-inflated state:
while the balloon remains in the partially-inflated state, pressing the flanges against a downstream surface of the native valve by moving the implant in an upstream direction; and
subsequently, by further inflating the balloon to a further-inflated state, further radially expanding the tubular frame.
In an application, inflating the balloon to a further-inflated state further includes increasing the inter-flange distance.
In an application:
exposing the flanges includes exposing the flanges while the flanges are positioned upstream of the native valve; and
the method further includes, prior to pressing the flanges against the downstream surface of the native valve, moving the exposed flanges to be downstream of the native valve.
In an application, partially inflating the balloon includes partially inflating the balloon while the flanges are positioned upstream of the native valve.
In an application, inflating the balloon to the further-inflated state includes inflating the balloon to the further-inflated state while continuing to press the flanges against the downstream surface.
In an application, exposing the flanges from the capsule includes moving a downstream capsule-portion of the capsule away from an upstream capsule-portion of the capsule.
In an application, advancing the implant includes advancing the implant while the tubular frame is disposed within the downstream capsule-portion, and the method further includes exposing the tubular frame from the downstream capsule-portion.
In an application, exposing the tubular frame from the downstream capsule-portion includes exposing the tubular frame from the downstream capsule-portion prior to pressing the flanges against the downstream surface of the native valve.
In an application, exposing the tubular frame from the downstream capsule-portion includes exposing the tubular frame entirely from the downstream capsule-portion without causing the tubular frame to expand.
In an application, the implant further includes a shape-memory upstream support portion, constrained within the capsule, and the method further includes, subsequent to pressing the flanges against a downstream surface of the native valve, exposing the upstream support portion from the capsule such that the upstream support portion automatically deflects radially outward.
In an application, exposing the upstream support portion includes exposing the upstream support portion such that the upstream support portion contacts an upstream surface of the native valve.
In an application:
advancing the implant disposed within the capsule, the tubular frame compressed around the balloon, includes advancing the implant disposed within the capsule, the tubular frame compressed around a body balloon-portion of the balloon;
the distal portion of the delivery tool includes one or more projections, each of the projections having a base-portion and a tip-portion;
advancing the distal portion of the delivery tool includes advancing the distal portion of the delivery tool while the one or more projections extend, from the shaft, over at least a downstream balloon-portion of the balloon toward the tubular frame, such that the tip-portion of each of the projections is closer than its corresponding base-portion to the tubular frame; and
pressing the flanges against the downstream surface by moving the implant in the upstream direction includes pushing the implant in the upstream direction by pushing the tip-portions against the tubular frame.
In an application, inflating the balloon includes inflating the balloon such that (i) the body balloon-portion radially expands the tubular frame by pressing radially outward against the tubular frame, and (ii) the downstream balloon-portion deflects the projections radially outward by pressing radially outward against the projections.
In an application, advancing the distal portion of the delivery tool includes advancing the distal portion of the delivery tool while the projections are disposed within the capsule, and the method further includes, prior to partially radially expanding the tubular frame, exposing at least the tip-portions of the projections from the capsule.
There is further provided, in accordance with an application of the present invention, an apparatus for delivery of a prosthetic heart valve to an annulus of a native heart valve, the apparatus including:
a shaft, having a longitudinal shaft-axis;
a capsule, disposed at a distal portion of the shaft;
a balloon, coupled to the shaft, and disposed within the capsule;
one or more projections extending distally from the shaft, such that the projections are arranged around a proximal portion of the balloon; and
a prosthetic valve, including a tubular frame, compressed around the balloon, and disposed within the capsule;
and:
the tubular frame is configured to remain compressed around the balloon upon exposure of the tubular frame from the capsule, such that:
inflation of the balloon applies a radial force to each of the projections; and
each of the projections is:
The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:
Reference is made to
Implant 20 comprises a tubular frame 30 that circumscribes a longitudinal axis ax1 to define a lumen 32 along axis ax1. Implant 20 typically further comprises at least one valve member (e.g., prosthetic leaflet 62) (
Implant 20 further comprises an outer frame 40 and one or more pins 50. Outer frame 40 is disposed radially outward from tubular frame 30, comprises one or more flanges 42, and defines one or more eyelets, e.g., outer eyelets 44. Typically, frame 40 comprises a plurality of flanges (e.g., 3-18, such as 6-12, such as 8-12 flanges). Typically, frame 40 defines a plurality of eyelets 44 (e.g., 3-18, such as 6-12, such as 8-12 eyelets). For some applications, the number of eyelets 44 is equal to the number of flanges. Further typically, the number of pins 50 is equal to the number of eyelets 44. In the embodiment shown, there are 12 eyelets, 12 flanges, and 12 pins.
Typically, and as shown, frame 40 circumscribes tubular frame 30. For example, frame 40 may comprise at least one ring 46 that circumscribes tubular frame 30, and to which flanges 42 are coupled. Ring 46 typically defines alternating peaks and troughs, e.g., being zigzag or wavy in shape.
Typically, tubular frame 30 also defines one or more eyelets, e.g., inner eyelets 34. Typically, frame 30 defines a plurality of eyelets 34 (e.g., 3-18, such as 6-12, such as 8-12 eyelets). Typically, the number of eyelets 34 is equal to the number of eyelets 44.
Outer frame 40 is composed of a shape-memory alloy such as nickel titanium (e.g., Nitinol), whereas tubular frame 30 and pins 50 are composed of a material that is not the shape-memory alloy. That is, frame 30 and pins 50 are both composed of the same material, and that material is not the shape-memory alloy of which frame 40 is composed. Typically, the material of which frame 30 and pins 50 are composed is not a shape-memory material of any kind. For example, frame 30 and pins 50 may be composed of steel (e.g., stainless steel, such as 316LVM) or a cobalt chrome alloy (e.g., MP35N or L605). It is to be noted that throughout this patent application (including the specification and the claims) the term “composed of” x means that x is the primary substance from which an element is made, such that x confers its properties on the element that is made of x.
Pins 50 couple outer frame 40 to tubular frame 30. Each pin 50 defines a shaft 52 and a head 54. Shaft 52 is passed radially-inwardly through an eyelet 44 to tubular frame 30, such that head 54 is disposed against outer frame 40, radially outward from the eyelet 44. Shaft 52 is welded to tubular frame 30. Typically, shaft 52 is also passed radially inwardly through a respective eyelet 34, and is welded to tubular frame 30 at eyelet 34. Because pin 50 and frame 30 are both composed of the same material, they may be welded together. In contrast, frame 40 is composed of a different material than pin 50, and coupling therebetween is provided by head 54, which is larger than eyelet 44.
Typically, each flange 42 has a root-portion 41 and a tip 43, and extends away from the tubular frame from the root-portion to the tip. Each outer eyelet 44 is typically defined at (e.g., by) the root-portion 41 of a respective flange 42, e.g., such that the head 54 of the respective pin 50 is disposed against the root-portion of the flange, radially outward from the eyelet.
There is therefore provided, in accordance with some applications of the invention, apparatus for use in a heart of a subject, the apparatus comprising:
wherein:
Typically, frame 40 is cut from a tube of the shape-memory alloy. Typically, frame 30 is cut (e.g., laser cut) from a tube of the other material. In order to facilitate implant 20 serving as a prosthetic heart valve, lumen 32 is typically lined with a lining 60 (e.g., comprising a fabric), and a plurality of prosthetic leaflets 62 (e.g., comprising bovine pericardium) are secured within the lumen, e.g., by suturing the leaflets to lining 36 and/or to frame 30. For the sake of clarity, lining 60, leaflets 62, and other fabric elements are omitted in
There is therefore further provided, in accordance with some applications of the invention, a method for constructing implant 20 (e.g., a prosthetic heart valve), the method comprising:
Typically, and as shown, implant 20 further comprises an upstream support portion 48, e.g., comprising a plurality of radial arms 49 optionally covered in an annular sheet. Further typically, it is outer frame 40 that defines upstream support portion 48, and therefore the upstream support portion is also composed of the shape-memory alloy. Flanges 42 extend radially outward from tubular frame 30, and toward upstream support portion 48. As discussed in more detail hereinbelow, flanges 42 are configured to engage a downstream surface of a native heart valve, and upstream support portion is configured (e.g., shaped and/or dimensioned) to be placed against an upstream surface of the native heart valve.
Frame 40 is shaped and memory-set such that, when unconstrained, upstream support portion 48 and flanges 42 extend radially outward from tubular frame 30. Typically, when unconstrained, flanges 42 are arranged in an array 56 around the outside of tubular frame 30, the array defining an inter-flange distance D58. Although inter-flange distance D58 is shown in
Reference is made to
Tool 100 comprises a shaft 106, a capsule 110, and a balloon 120, which is typically a non-compliant balloon. Shaft 106 has a central longitudinal shaft-axis ax2, which typically is the same as, or is collinear with, a central longitudinal axis of tool 100. Capsule 110 is disposed at a distal portion 104 of the tool (e.g., at a distal end of shaft 106), and comprises an upstream capsule-portion 112 and a downstream capsule-portion 114, and is openable by moving the upstream capsule-portion and the downstream capsule-portion apart. Balloon 120 is coupled to shaft 106, and is disposed within capsule 110 (e.g., downstream capsule-portion 114 thereof). As shown, tool 100 typically comprises a controller and/or handle 108 at a proximal portion 102 of the tool.
As described hereinabove, outer frame 40 of implant 20 is composed of a shape-memory alloy. Flanges 42 are shape-set to protrude radially outward. Upstream support portion 48 is (e.g., arms 49 thereof are) also shape-set to protrude radially outward. As described in more detail with reference to
In the delivery state of the apparatus, balloon 120 is typically disposed within capsule 110, flanges 42 are typically constrained within downstream capsule-portion 114, and upstream support portion 48 is typically constrained within upstream capsule-portion 112. For some applications, the term “within” means “entirely within,” i.e., with no part of the balloon, flange, or upstream support portion disposed outside of the capsule or capsule-portion. For some applications, the term “within” means “at least partly within,” i.e., part of the balloon, flange, or upstream support portion may be disposed outside of the capsule or capsule-portion.
There is therefore provided, in accordance with some applications of the invention, apparatus comprising:
wherein:
Balloon 120 has an upstream (e.g., distal) balloon-portion 122, a downstream (e.g., proximal) balloon-portion 126, and a body (e.g., intermediary) balloon-portion 124 therebetween. Body balloon-portion 124 typically comprises the widest part of balloon 120. Typically, body balloon-portion 124 is disposed within lumen 32 of tubular frame 30. That is, for delivery, tubular frame 30 is typically compressed around body balloon-portion 25. As shown in
Typically, balloon 120 is fixed to shaft 106, e.g., by at least one end of the balloon being attached to the shaft. For example, and as shown, balloon-portion 124 may be attached to shaft 106. Tool 100 defines an inflation channel 119 from proximal portion 102 to distal portion 104. For some applications, and as shown, tool 100 comprises a pipe 118 through which shaft 106 extends, and channel 119 is defined between the pipe and the channel. For such applications, balloon-portion 126 of balloon 120 is typically attached to pipe 118, placing balloon 120 in fluid communication with channel 119 such that the balloon is inflatable via the channel.
Typically, pipe 118 is fixed with respect to shaft 106. However, both upstream capsule-portion 112 and downstream capsule-portion 114 are typically axially movable with respect to shaft 106, such as by one of the capsule-portions being attached to a rod 116 that is slidable through the shaft, and the other one of the capsule-portions being attached to a tube (not shown) that is slidable over the shaft. For example, and as shown, capsule-portion 112 may be attached to rod 116, and capsule-portion 114 may be attached to the tube. Upstream capsule-portion 112 is retractable from over upstream support portion 48 by being moved away from balloon 120 (i.e., in an upstream direction), and downstream capsule-portion 114 is retractable from over flanges 42 by being moved away from the balloon (i.e., in a downstream direction).
Typically, tool 100 comprises one or more (typically a plurality of) elongate projections 130. Projections 130 are configured to apply an axial pushing force against implant 20 (e.g., tubular frame 30 thereof), in order to maintain the positioning of the implant during deployment. For example, and as described in more detail with reference to
During delivery (i.e., in a delivery state of tool 100 and implant 20), projections 130 are typically disposed within downstream capsule-portion 114. Each projection 130 has a tip-portion (e.g., a free end) 132, and a base-portion 134. Base-portion 134 is disposed deeper into the downstream capsule-portion than is tip-portion 132. Projections 130 are arranged circumferentially around shaft-axis ax2, such that tip-portions 132 are arranged circumferentially around balloon-portion 126 of balloon 120, with the tip-portion of each projection being closer than its corresponding base-portion 134 to tubular frame 30. Typically, in the delivery state, tip-portions 132 abut tubular frame 30 (e.g., a proximal and/or downstream surface thereof). However, projections 130 (e.g., tip-portions 132 thereof) are typically not attached to tubular frame 30. Therefore, after expansion of tubular frame 30 and deflation of balloon 120 (e.g., as described with reference to
Tool 100 is typically configured to facilitate continued application, by projections 130, of the axial pushing force against tubular frame 30 while the tubular frame is being expanded, despite the presence of tapered balloon-portion 126. This feature, and its advantages, are discussed in more detail hereinbelow with reference to
The apparatus may be configured such that projections 130 deflect simultaneously and/or at the same rate that the tubular frame expands, allowing contact between the projections and the tubular frame to be maintained. For example, tubular frame 30 may define a frame-circumference, the tip-portions may collectively define a projection-circumference, and while the tubular frame and the tip-portions are exposed from the downstream capsule-portion, inflation of balloon 120 may increase the projection-circumference at the same rate as it increases the frame-circumference.
Each projection 130 is therefore sufficiently flexible (e.g., radially flexible) that it is deflected by a radial force F1 applied by the radial expansion of balloon-portion 126. Nonetheless, as described hereinabove, each projection 130 is also typically capable of applying an axial pushing force F2 of at least 0.5 N to tubular frame 30 (e.g., to overcome an axial resistance force F3, of frame 30 against the projections, in the opposite direction of force F2). Forces F1, F2, and F3 are indicated in
For some applications of the invention, this configuration is facilitated by each projection 130 being non-isometrically flexible. For example, each projection 130 may have a radial stiffness in its radial plane 136, and a lateral stiffness in its lateral plane 138, the lateral stiffness being greater than (e.g., more than twice as great as) the radial stiffness. For clarity, radial plane 136 is a plane on which the projection and axis ax2 lie, and in which the projection deflects, and lateral plane 138 is typically transverse to the radial plane. Lateral plane 138 may also be tangential to the projection-circumference collectively defined by the tip-portions of projections 130.
For some applications of the invention, outward radial force F1 is of a greater magnitude than axial resistance force F3. It is hypothesized by the inventors that, for at least some such applications of the invention, F1 being greater than F3 facilitates deflection of projections 130 simultaneously with the projections axially pushing tubular frame 30.
For some applications, and as shown, tip-portions 132 are shaped to define a face that has a greater transverse cross-sectional area than parts of projection 130 that are closer to base-portion 134. These faces are visible in
Reference is now made to
While tool 100 and implant 20 are in the delivery state (e.g., with capsule 110 closed, and implant 20 compressed therewithin), tool 100 is transapically advanced into left ventricle 8 (
Flanges 42 are subsequently pressed against a downstream surface of native valve 10 by moving implant 20 in an upstream direction (
As shown in
Subsequently, upstream support portion 48 is exposed from capsule-portion 112 and automatically deflects radially outward, e.g., contacting an upstream surface of native valve 10 (
While flanges 42 remain in contact with the downstream surface of the native valve, and typically while upstream support portion 48 remains in contact with the upstream surface of the native valve, tubular frame 30 is plastically expanded radially by inflating balloon 120 (
After implant 20 has been implanted and expanded, balloon 120 is deflated, and tool 100 is removed from the subject, typically after closing capsule 110 (
Reference is now made to
Tool 200 is identical to tool 100, except that it comprises projections 230 instead of projections 130. Projections 230 are identical to projections 130, except that they are more rigid. Projections 330 are identical to projections 130 except that they are shorter, and therefore do not extend over balloon-portion 126 to implant 180. (Projections 330 may be flexible like projections 130 or rigid like projections 230.) As described hereinabove, tool 100 is typically configured to facilitate continued application, by projections 130, of the axial pushing force against tubular frame 30 while the tubular frame is being expanded, despite the presence of tapered balloon-portion 126. The advantage conferred by projections 130 may be illustrated by the following comparison of the results of using tool 200 and/or tool 300, to the result of using tool 100.
As described hereinabove, body balloon-portion 124 is typically cylindrical, and balloon-portions 122 and 126 typically taper away from the body balloon-portion. A balloon of this shape advantageously can withstand a greater inflation pressure than can a similar balloon that is entirely cylindrical (i.e., with flat ends). However, in order to expand implant 180 evenly, the implant is disposed around body balloon-portion 124, which is cylindrical when inflated.
Before inflation of balloon 120, there is no difference between using tool 100 and using tool 200. When balloon 120 of tool 100 is inflated, projections 130 are pushed radially outward by the balloon, allowing downstream balloon-portion 126 (over which the projections are disposed) to assume its conical shape, and body balloon-portion 124 to assume its cylindrical shape, thereby evenly expanding implant 180. When inflated, balloon 120 typically fills the lumen of implant 180 uniformly.
In contrast, when balloon 120 of tool 200 is inflated, projections 130 are not pushed radially outward by the balloon, and instead constrain balloon-portion 126 (over which the projections are disposed) from expanding. Therefore, a downstream region 124a of body balloon-portion 124 is inhibited from fully inflating and joining the rest of the body balloon-portion in becoming cylindrical. Therefore, the part of implant 180 that is disposed around region 124a is not expanded to the same degree as other parts of the implant. That is, implant 180 is not expanded evenly.
Projections 330 of tool 300 do not extend over balloon-portion 126 to implant 180, and therefore do not constrain balloon-portion 126 from expanding. However, because they do not reach implant 180, they are unable to serve the function of applying the axial force to the implant in order to correctly position the implant during implantation. Furthermore, in some instances, implant 180 may slip with respect to balloon 120 and become positioned over conical balloon-portion 126 or 122, which, as described hereinabove, may result in uneven expansion of the implant.
Therefore, the particular quality of projections 130 to be both (i) sufficiently rigid to apply the axial force to an implant, and (ii) sufficiently radially flexible to be pushed radially outward by balloon 120, provides tool 100 with the ability to both (i) control the position of an implant, and (ii) to evenly expand the implant.
Reference is made to
Although
For some applications, it may be desirable to at least partially expand tubular frame and/or array 56 of flanges 42, prior to the flanges contacting the downstream surface of native valve 10.
Subsequently, upstream support portion 48 is exposed from capsule 110 while flanges 42 remain in contact with the downstream surface (e.g., continue to press against the downstream surface), while inter-flange distance D58 remains partially increased, and typically while balloon 120 remains partially inflated (
Subsequently, balloon 120 is further inflated to the further-inflated state further radially expanding tubular frame 30 (
For some applications, it may be desirable to expose flanges 42 from capsule 110 and/or at least partially expand array 56, while the flanges are disposed upstream of the native valve 10 (e.g., within atrium 6), and to subsequently move the flanges downstream of the native valve (e.g., within ventricle 8) while the flanges remain in this state.
For some applications, and as shown in
Subsequently, tool 100 is moved downstream (proximally, for a transapical approach) until the leaflets are observed (e.g., using fluoroscopy and/or ultrasound) to coapt upstream of flanges 42 (
For some applications in which flanges 42 are exposed upstream of the native valve, balloon 120 is partially inflated only after the exposed flanges are moved downstream of the native valve (embodiment not shown).
There is therefore provided, in accordance with some applications of the invention, method comprising:
advancing, to the heart:
subsequently, exposing the flanges from the capsule such that the flanges automatically deflect radially outward away from the tubular frame, and such that the array defines an inter-flange distance;
subsequently, by partially inflating the balloon to a partially-inflated state:
while the balloon remains in the partially-inflated state, pressing the flanges against a downstream surface of the native valve by moving the implant in an upstream direction; and
subsequently, by further inflating the balloon to a further-inflated state, further radially expanding the tubular frame.
There is further provided, in accordance with some applications of the invention (e.g., as described in reference to
exposing the flanges comprises exposing the flanges while the flanges are positioned upstream of the native valve; and
the method further comprises, prior to pressing the flanges against the downstream surface of the native valve, moving the exposed flanges to be downstream of the native valve.
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
Number | Date | Country | Kind |
---|---|---|---|
1720803 | Dec 2017 | GB | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/IL2018/051350 | 12/12/2018 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2019/116369 | 6/20/2019 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3874388 | King et al. | Apr 1975 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4261342 | Aranguren | Apr 1981 | A |
4275469 | Gabbay | Jun 1981 | A |
4340091 | Skelton et al. | Jul 1982 | A |
4423525 | Vallana et al. | Jan 1984 | A |
4853986 | Allen | Aug 1989 | A |
4892541 | Alonso | Jan 1990 | A |
4972494 | White et al. | Nov 1990 | A |
4994077 | Dobben | Feb 1991 | A |
5078739 | Martin | Jan 1992 | A |
5108420 | Marks | Apr 1992 | A |
5201757 | Heyn | Apr 1993 | A |
5314473 | Godin | May 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5397351 | Pavcnik et al. | Mar 1995 | A |
5405378 | Strecker | Apr 1995 | A |
5443500 | Sigwart | Aug 1995 | A |
5473812 | Morris et al. | Dec 1995 | A |
5607444 | Lam | Mar 1997 | A |
5607470 | Milo | Mar 1997 | A |
5647857 | Anderson et al. | Jul 1997 | A |
5702397 | Goble et al. | Dec 1997 | A |
5713948 | Uflacker | Feb 1998 | A |
5716417 | Girard et al. | Feb 1998 | A |
5741297 | Simon | Apr 1998 | A |
5765682 | Bley et al. | Jun 1998 | A |
5776140 | Cottone | Jul 1998 | A |
5868777 | Lam | Feb 1999 | A |
5873906 | Lau et al. | Feb 1999 | A |
5954766 | Zadno-Azizi et al. | Sep 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5980565 | Jayaraman | Nov 1999 | A |
6010530 | Goicoechea | Jan 2000 | A |
6019787 | Richard et al. | Feb 2000 | A |
6042607 | Williamson, IV | Mar 2000 | A |
6059827 | Fenton | May 2000 | A |
6074417 | Peredo | Jun 2000 | A |
6113612 | Swanson et al. | Sep 2000 | A |
6120534 | Ruiz | Sep 2000 | A |
6126686 | Badylak et al. | Oct 2000 | A |
6152937 | Peterson et al. | Nov 2000 | A |
6165183 | Kuehn et al. | Dec 2000 | A |
6165210 | Lau et al. | Dec 2000 | A |
6187020 | Zegdi et al. | Feb 2001 | B1 |
6193686 | Estrada et al. | Feb 2001 | B1 |
6193745 | Fogarty et al. | Feb 2001 | B1 |
6254609 | Vrba | Jul 2001 | B1 |
6264700 | Kilcoyne et al. | Jul 2001 | B1 |
6287339 | Vasquez et al. | Sep 2001 | B1 |
6312465 | Griffin et al. | Nov 2001 | B1 |
6332893 | Mortier et al. | Dec 2001 | B1 |
6334873 | Lane et al. | Jan 2002 | B1 |
6346074 | Roth | Feb 2002 | B1 |
6350278 | Lenker et al. | Feb 2002 | B1 |
6352561 | Leopold et al. | Mar 2002 | B1 |
6391036 | Berg et al. | May 2002 | B1 |
6402780 | Williamson, IV | Jun 2002 | B2 |
6409755 | Vrba | Jun 2002 | B1 |
6419696 | Ortiz et al. | Jul 2002 | B1 |
6428550 | Vargas et al. | Aug 2002 | B1 |
6440164 | Dimatteo et al. | Aug 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6478807 | Foreman et al. | Nov 2002 | B1 |
6482228 | Norred | Nov 2002 | B1 |
6491711 | Durcan | Dec 2002 | B1 |
6511491 | Grudem et al. | Jan 2003 | B2 |
6530952 | Vesely | Mar 2003 | B2 |
6540782 | Snyders | Apr 2003 | B1 |
6551350 | Thornton et al. | Apr 2003 | B1 |
6558396 | Inoue | May 2003 | B1 |
6558418 | Carpentier et al. | May 2003 | B2 |
6569196 | Vesely | May 2003 | B1 |
6602263 | Swanson et al. | Aug 2003 | B1 |
6616675 | Evard et al. | Sep 2003 | B1 |
6652556 | VanTassel et al. | Nov 2003 | B1 |
6669724 | Park et al. | Dec 2003 | B2 |
6682558 | Tu et al. | Jan 2004 | B2 |
6699256 | Logan et al. | Mar 2004 | B1 |
6716244 | Klaco | Apr 2004 | B2 |
6719781 | Kim | Apr 2004 | B1 |
6719788 | Cox | Apr 2004 | B2 |
6730118 | Spenser et al. | May 2004 | B2 |
6733525 | Yang et al. | May 2004 | B2 |
6752813 | Goldfarb et al. | Jun 2004 | B2 |
6764518 | Godin | Jul 2004 | B2 |
6767362 | Schreck | Jul 2004 | B2 |
6797002 | Spence et al. | Sep 2004 | B2 |
6821297 | Snyders | Nov 2004 | B2 |
6830585 | Artof et al. | Dec 2004 | B1 |
6830638 | Boylan et al. | Dec 2004 | B2 |
6884257 | Cox et al. | Apr 2005 | B1 |
6893460 | Spenser et al. | May 2005 | B2 |
6926715 | Hauck et al. | Aug 2005 | B1 |
6951571 | Srivastava | Oct 2005 | B1 |
6960217 | Bolduc | Nov 2005 | B2 |
6964684 | Ortiz et al. | Nov 2005 | B2 |
6974476 | McGuckin et al. | Dec 2005 | B2 |
7011681 | Vesely | Mar 2006 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7041132 | Quijano et al. | May 2006 | B2 |
7074236 | Rabkin | Jul 2006 | B2 |
7077861 | Spence | Jul 2006 | B2 |
7101395 | Tremulis et al. | Sep 2006 | B2 |
7101396 | Artof et al. | Sep 2006 | B2 |
7137184 | Schreck | Nov 2006 | B2 |
7172625 | Shu et al. | Feb 2007 | B2 |
7175656 | Khairkhahan | Feb 2007 | B2 |
7198646 | Figulla et al. | Apr 2007 | B2 |
7201772 | Schwammenthal | Apr 2007 | B2 |
7226467 | Lucatero et al. | Jun 2007 | B2 |
7226477 | Cox | Jun 2007 | B2 |
7261686 | Couvillon, Jr. | Aug 2007 | B2 |
7288097 | Séguin | Oct 2007 | B2 |
7288111 | Holloway et al. | Oct 2007 | B1 |
7316716 | Egan | Jan 2008 | B2 |
7329279 | Haug et al. | Feb 2008 | B2 |
7335213 | Hyde et al. | Feb 2008 | B1 |
7351256 | Hojeibane et al. | Apr 2008 | B2 |
7374573 | Gabbay | May 2008 | B2 |
7377938 | Sarac et al. | May 2008 | B2 |
7381218 | Schreck | Jun 2008 | B2 |
7381219 | Salahieh et al. | Jun 2008 | B2 |
7404824 | Webler et al. | Jul 2008 | B1 |
7422603 | Lane | Sep 2008 | B2 |
7429269 | Schwammenthal | Sep 2008 | B2 |
7442204 | Schwammenthal | Oct 2008 | B2 |
7445630 | Lashinski et al. | Nov 2008 | B2 |
7455677 | Vargas et al. | Nov 2008 | B2 |
7455688 | Furst et al. | Nov 2008 | B2 |
7462162 | Phan et al. | Dec 2008 | B2 |
7481838 | Carpentier et al. | Jan 2009 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7513909 | Lane et al. | Apr 2009 | B2 |
7527646 | Randert et al. | May 2009 | B2 |
7556632 | Zadno | Jul 2009 | B2 |
7556646 | Yang et al. | Jul 2009 | B2 |
7563267 | Goldfarb et al. | Jul 2009 | B2 |
7563273 | Goldfarb et al. | Jul 2009 | B2 |
7582111 | Krolik et al. | Sep 2009 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7597711 | Drews et al. | Oct 2009 | B2 |
7608091 | Goldfarb et al. | Oct 2009 | B2 |
7611534 | Kapadia et al. | Nov 2009 | B2 |
7621948 | Hermann et al. | Nov 2009 | B2 |
7625403 | Krivoruchko | Dec 2009 | B2 |
7632302 | Vreeman et al. | Dec 2009 | B2 |
7635329 | Goldfarb et al. | Dec 2009 | B2 |
7648528 | Styrc | Jan 2010 | B2 |
7655015 | Goldfarb et al. | Feb 2010 | B2 |
7682380 | Thornton et al. | Mar 2010 | B2 |
7708775 | Rowe et al. | May 2010 | B2 |
7717952 | Case et al. | May 2010 | B2 |
7717955 | Lane et al. | May 2010 | B2 |
7731741 | Eidenschink | Jun 2010 | B2 |
7736388 | Goldfarb et al. | Jun 2010 | B2 |
7748389 | Salahieh et al. | Jul 2010 | B2 |
7753922 | Starksen | Jul 2010 | B2 |
7753949 | Lamphere | Jul 2010 | B2 |
7758595 | Allen et al. | Jul 2010 | B2 |
7758632 | Hojeibane et al. | Jul 2010 | B2 |
7758640 | Vesely | Jul 2010 | B2 |
7771467 | Svensson | Aug 2010 | B2 |
7771469 | Liddicoat | Aug 2010 | B2 |
7776080 | Bei et al. | Aug 2010 | B2 |
7776083 | Vesely | Aug 2010 | B2 |
7780726 | Seguin | Aug 2010 | B2 |
7785341 | Forster et al. | Aug 2010 | B2 |
7799069 | Bailey et al. | Sep 2010 | B2 |
7803181 | Furst et al. | Sep 2010 | B2 |
7811296 | Goldfarb et al. | Oct 2010 | B2 |
7811316 | Kalmann et al. | Oct 2010 | B2 |
7824442 | Salahieh et al. | Nov 2010 | B2 |
7837645 | Bessler et al. | Nov 2010 | B2 |
7837727 | Goetz et al. | Nov 2010 | B2 |
7842081 | Yadin | Nov 2010 | B2 |
7850725 | Vardi et al. | Dec 2010 | B2 |
7871432 | Bergin | Jan 2011 | B2 |
7871436 | Ryan et al. | Jan 2011 | B2 |
7887583 | Macoviak | Feb 2011 | B2 |
7892281 | Seguin et al. | Feb 2011 | B2 |
7896915 | Guyenot et al. | Mar 2011 | B2 |
7914544 | Nguyen et al. | Mar 2011 | B2 |
7914569 | Nguyen et al. | Mar 2011 | B2 |
7927370 | Webler et al. | Apr 2011 | B2 |
7942927 | Kaye et al. | May 2011 | B2 |
7947072 | Yang et al. | May 2011 | B2 |
7947075 | Goetz et al. | May 2011 | B2 |
7955375 | Agnew | Jun 2011 | B2 |
7955377 | Melsheimer | Jun 2011 | B2 |
7955384 | Rafiee et al. | Jun 2011 | B2 |
7959666 | Salahieh et al. | Jun 2011 | B2 |
7959672 | Salahieh et al. | Jun 2011 | B2 |
7967833 | Sterman et al. | Jun 2011 | B2 |
7967857 | Lane | Jun 2011 | B2 |
7981151 | Rowe | Jul 2011 | B2 |
7981153 | Fogarty et al. | Jul 2011 | B2 |
7992567 | Hirotsuka et al. | Aug 2011 | B2 |
7993393 | Carpentier et al. | Aug 2011 | B2 |
8002825 | Letac et al. | Aug 2011 | B2 |
8002826 | Seguin | Aug 2011 | B2 |
8016877 | Seguin et al. | Sep 2011 | B2 |
8016882 | Macoviak | Sep 2011 | B2 |
8021420 | Dolan | Sep 2011 | B2 |
8021421 | Fogarty et al. | Sep 2011 | B2 |
8025695 | Fogarty et al. | Sep 2011 | B2 |
8029518 | Goldfarb et al. | Oct 2011 | B2 |
8029557 | Sobrino-Serrano et al. | Oct 2011 | B2 |
8029564 | Johnson et al. | Oct 2011 | B2 |
8034104 | Carpentier et al. | Oct 2011 | B2 |
8038720 | Wallace et al. | Oct 2011 | B2 |
8043360 | McNamara et al. | Oct 2011 | B2 |
8048138 | Sulivan et al. | Nov 2011 | B2 |
8048140 | Purdy | Nov 2011 | B2 |
8048153 | Salahieh et al. | Nov 2011 | B2 |
8052592 | Goldfarb et al. | Nov 2011 | B2 |
8052741 | Bruszewski et al. | Nov 2011 | B2 |
8052749 | Salahieh et al. | Nov 2011 | B2 |
8057493 | Goldfarb et al. | Nov 2011 | B2 |
8057532 | Hoffman | Nov 2011 | B2 |
8057540 | Letac et al. | Nov 2011 | B2 |
8062355 | Figulla et al. | Nov 2011 | B2 |
8062359 | Marquez et al. | Nov 2011 | B2 |
8070708 | Rottenberg et al. | Dec 2011 | B2 |
8070800 | Lock et al. | Dec 2011 | B2 |
8070802 | Lamphere et al. | Dec 2011 | B2 |
8070804 | Hyde | Dec 2011 | B2 |
8075611 | Milwee et al. | Dec 2011 | B2 |
8080054 | Rowe | Dec 2011 | B2 |
8083793 | Lane et al. | Dec 2011 | B2 |
D652927 | Braido et al. | Jan 2012 | S |
D653341 | Braido et al. | Jan 2012 | S |
8092518 | Schreck | Jan 2012 | B2 |
8092520 | Quadri | Jan 2012 | B2 |
8092521 | Figulla et al. | Jan 2012 | B2 |
8105377 | Liddicoat | Jan 2012 | B2 |
8109996 | Stacchino et al. | Feb 2012 | B2 |
8118866 | Herrmann et al. | Feb 2012 | B2 |
8133270 | Kheradvar et al. | Mar 2012 | B2 |
8136218 | Millwee et al. | Mar 2012 | B2 |
8137398 | Tuval et al. | Mar 2012 | B2 |
8142492 | Forster et al. | Mar 2012 | B2 |
8142494 | Randert et al. | Mar 2012 | B2 |
8142496 | Berreklouw | Mar 2012 | B2 |
8142497 | Friedman | Mar 2012 | B2 |
8147504 | Ino et al. | Apr 2012 | B2 |
8157852 | Bloom et al. | Apr 2012 | B2 |
8157853 | Laske et al. | Apr 2012 | B2 |
8157860 | McNamara et al. | Apr 2012 | B2 |
8163008 | Wilson et al. | Apr 2012 | B2 |
8163014 | Lane et al. | Apr 2012 | B2 |
D660433 | Braido et al. | May 2012 | S |
D660967 | Braido et al. | May 2012 | S |
8167894 | Miles et al. | May 2012 | B2 |
8167932 | Bourang et al. | May 2012 | B2 |
8167935 | McGuckin, Jr. et al. | May 2012 | B2 |
8172896 | McNamara et al. | May 2012 | B2 |
8172898 | Alferness et al. | May 2012 | B2 |
8177836 | Lee et al. | May 2012 | B2 |
8182528 | Salahieh et al. | May 2012 | B2 |
8211169 | Lane et al. | Jul 2012 | B2 |
8216256 | Raschdorf, Jr. et al. | Jul 2012 | B2 |
8216301 | Bonhoeffer et al. | Jul 2012 | B2 |
8221492 | Case et al. | Jul 2012 | B2 |
8221493 | Boyle et al. | Jul 2012 | B2 |
8226710 | Nguyen et al. | Jul 2012 | B2 |
8231670 | Salahieh et al. | Jul 2012 | B2 |
8236045 | Benichou et al. | Aug 2012 | B2 |
8236049 | Rowe et al. | Aug 2012 | B2 |
8252042 | McNamara et al. | Aug 2012 | B2 |
8252051 | Chau et al. | Aug 2012 | B2 |
8252052 | Salahieh et al. | Aug 2012 | B2 |
8257390 | Carley et al. | Sep 2012 | B2 |
8267988 | Hamer et al. | Sep 2012 | B2 |
8277501 | Chalekian et al. | Oct 2012 | B2 |
8287591 | Keidar et al. | Oct 2012 | B2 |
8298280 | Yadin et al. | Oct 2012 | B2 |
8303653 | Bonhoeffer et al. | Nov 2012 | B2 |
8308798 | Pintor et al. | Nov 2012 | B2 |
8317853 | Agnew | Nov 2012 | B2 |
8317855 | Gregorich et al. | Nov 2012 | B2 |
8323335 | Rowe et al. | Dec 2012 | B2 |
8328868 | Paul et al. | Dec 2012 | B2 |
8337541 | Quadri et al. | Dec 2012 | B2 |
8343174 | Goldfarb et al. | Jan 2013 | B2 |
8343213 | Salahieh et al. | Jan 2013 | B2 |
8348999 | Kheradvar et al. | Jan 2013 | B2 |
8366767 | Zhang | Feb 2013 | B2 |
8372140 | Hoffman et al. | Feb 2013 | B2 |
8377119 | Drews et al. | Feb 2013 | B2 |
8398708 | Meiri et al. | Mar 2013 | B2 |
8403981 | Forster et al. | Mar 2013 | B2 |
8403983 | Quadri et al. | Mar 2013 | B2 |
8408214 | Spenser | Apr 2013 | B2 |
8414644 | Quadri et al. | Apr 2013 | B2 |
8425593 | Braido et al. | Apr 2013 | B2 |
8430934 | Das | Apr 2013 | B2 |
8444689 | Zhang | May 2013 | B2 |
8449599 | Chau et al. | May 2013 | B2 |
8449625 | Campbell et al. | May 2013 | B2 |
8454686 | Alkhatib | Jun 2013 | B2 |
8460365 | Haverkost et al. | Jun 2013 | B2 |
8474460 | Barrett et al. | Jul 2013 | B2 |
8500821 | Sobrino-Serrano et al. | Aug 2013 | B2 |
8512400 | Tran et al. | Aug 2013 | B2 |
8539662 | Stacchino et al. | Sep 2013 | B2 |
8540767 | Zhang | Sep 2013 | B2 |
8545544 | Spenser et al. | Oct 2013 | B2 |
8551160 | Figulla et al. | Oct 2013 | B2 |
8551161 | Dolan | Oct 2013 | B2 |
8562672 | Bonhoeffer et al. | Oct 2013 | B2 |
8568475 | Nguyen et al. | Oct 2013 | B2 |
8579964 | Lane et al. | Nov 2013 | B2 |
8579965 | Bonhoeffer et al. | Nov 2013 | B2 |
8585755 | Chau et al. | Nov 2013 | B2 |
8585756 | Bonhoeffer et al. | Nov 2013 | B2 |
8591460 | Wilson et al. | Nov 2013 | B2 |
8591570 | Revuelta et al. | Nov 2013 | B2 |
8623075 | Murray et al. | Jan 2014 | B2 |
8623080 | Fogarty et al. | Jan 2014 | B2 |
8628569 | Benichou et al. | Jan 2014 | B2 |
8628570 | Seguin | Jan 2014 | B2 |
8628571 | Hacohen et al. | Jan 2014 | B1 |
8652203 | Quadri et al. | Feb 2014 | B2 |
8652204 | Quill et al. | Feb 2014 | B2 |
8657872 | Seguin | Feb 2014 | B2 |
8663322 | Keranen | Mar 2014 | B2 |
8673020 | Sobrino-Serrano et al. | Mar 2014 | B2 |
8679174 | Ottma et al. | Mar 2014 | B2 |
8685086 | Navia et al. | Apr 2014 | B2 |
8696742 | Pintor et al. | Apr 2014 | B2 |
8728155 | Montorfano et al. | May 2014 | B2 |
8734507 | Keranen | May 2014 | B2 |
8747460 | Tuval et al. | Jun 2014 | B2 |
8771345 | Tuval et al. | Jul 2014 | B2 |
8784472 | Eidenschink | Jul 2014 | B2 |
8784479 | Antonsson et al. | Jul 2014 | B2 |
8784481 | Alkhatib et al. | Jul 2014 | B2 |
8795355 | Alkhatib | Aug 2014 | B2 |
8795356 | Quadri et al. | Aug 2014 | B2 |
8795357 | Yohanan et al. | Aug 2014 | B2 |
8801776 | House et al. | Aug 2014 | B2 |
8808366 | Braido et al. | Aug 2014 | B2 |
8840663 | Salahieh et al. | Sep 2014 | B2 |
8840664 | Karapetian et al. | Sep 2014 | B2 |
8845722 | Gabbay | Sep 2014 | B2 |
8852261 | White | Oct 2014 | B2 |
8852272 | Gross et al. | Oct 2014 | B2 |
8870948 | Erzberger et al. | Oct 2014 | B1 |
8870949 | Rowe | Oct 2014 | B2 |
8870950 | Hacohen | Oct 2014 | B2 |
8876800 | Behan | Nov 2014 | B2 |
8894702 | Quadri et al. | Nov 2014 | B2 |
8900294 | Paniagua et al. | Dec 2014 | B2 |
8900295 | Migliazza et al. | Dec 2014 | B2 |
8906083 | Obermiller et al. | Dec 2014 | B2 |
8911455 | Quadri et al. | Dec 2014 | B2 |
8911489 | Ben-Muvhar | Dec 2014 | B2 |
8911493 | Rowe et al. | Dec 2014 | B2 |
8932343 | Alkhatib et al. | Jan 2015 | B2 |
8961595 | Alkhatib | Feb 2015 | B2 |
8979922 | Jayasinghe et al. | Mar 2015 | B2 |
8986370 | Annest | Mar 2015 | B2 |
8986373 | Chau et al. | Mar 2015 | B2 |
8986375 | Garde et al. | Mar 2015 | B2 |
8992599 | Thubrikar et al. | Mar 2015 | B2 |
8992604 | Gross et al. | Mar 2015 | B2 |
8992608 | Haug et al. | Mar 2015 | B2 |
8998982 | Richter et al. | Apr 2015 | B2 |
9005273 | Salahieh et al. | Apr 2015 | B2 |
9011527 | Li et al. | Apr 2015 | B2 |
9017399 | Gross et al. | Apr 2015 | B2 |
D730520 | Braido et al. | May 2015 | S |
D730521 | Braido et al. | May 2015 | S |
9023100 | Quadri et al. | May 2015 | B2 |
9034032 | McLean et al. | May 2015 | B2 |
9034033 | McLean et al. | May 2015 | B2 |
9039757 | McLean et al. | May 2015 | B2 |
D732666 | Nguyen et al. | Jun 2015 | S |
9050188 | Schweich et al. | Jun 2015 | B2 |
9060858 | Thornton et al. | Jun 2015 | B2 |
9072603 | Tuval et al. | Jul 2015 | B2 |
9084676 | Chau et al. | Jul 2015 | B2 |
9095434 | Rowe | Aug 2015 | B2 |
9119719 | Zipory | Sep 2015 | B2 |
9125738 | Figulla et al. | Sep 2015 | B2 |
9125740 | Morriss et al. | Sep 2015 | B2 |
9132006 | Spenser et al. | Sep 2015 | B2 |
9132009 | Hacohen et al. | Sep 2015 | B2 |
9138312 | Tuval et al. | Sep 2015 | B2 |
9155619 | Liu et al. | Oct 2015 | B2 |
9173659 | Bodewadt et al. | Nov 2015 | B2 |
9173738 | Murray et al. | Nov 2015 | B2 |
9220594 | Braido et al. | Dec 2015 | B2 |
9226820 | Braido et al. | Jan 2016 | B2 |
9226839 | Kariniemi et al. | Jan 2016 | B1 |
9232995 | Kovalsky et al. | Jan 2016 | B2 |
9241790 | Lane et al. | Jan 2016 | B2 |
9241791 | Braido et al. | Jan 2016 | B2 |
9241792 | Benichou et al. | Jan 2016 | B2 |
9241794 | Braido et al. | Jan 2016 | B2 |
9248014 | Lane et al. | Feb 2016 | B2 |
9277994 | Miller | Mar 2016 | B2 |
9289290 | Alkhatib et al. | Mar 2016 | B2 |
9289291 | Gorman et al. | Mar 2016 | B2 |
9295550 | Nguyen et al. | Mar 2016 | B2 |
9295551 | Straubinger | Mar 2016 | B2 |
9295552 | McLean et al. | Mar 2016 | B2 |
9301836 | Buchbinder et al. | Apr 2016 | B2 |
9320591 | Bolduc | Apr 2016 | B2 |
D755384 | Pesce et al. | May 2016 | S |
9326852 | Spenser | May 2016 | B2 |
9326876 | Acosta et al. | May 2016 | B2 |
9345573 | Nyuli et al. | May 2016 | B2 |
9387078 | Gross et al. | Jul 2016 | B2 |
9393110 | Levi | Jul 2016 | B2 |
9421098 | Gifford et al. | Aug 2016 | B2 |
9427303 | Liddy et al. | Aug 2016 | B2 |
9427316 | Schweich, Jr. et al. | Aug 2016 | B2 |
9439757 | Wallace et al. | Sep 2016 | B2 |
9463102 | Kelly | Oct 2016 | B2 |
9474638 | Robinson et al. | Oct 2016 | B2 |
9480559 | Vidlund et al. | Nov 2016 | B2 |
9492273 | Wallace et al. | Nov 2016 | B2 |
9498314 | Behan | Nov 2016 | B2 |
9498332 | Hacohen et al. | Nov 2016 | B2 |
9510947 | Straubinger et al. | Dec 2016 | B2 |
9532870 | Cooper et al. | Jan 2017 | B2 |
9554897 | Lane et al. | Jan 2017 | B2 |
9554899 | Granada et al. | Jan 2017 | B2 |
9561103 | Granada et al. | Feb 2017 | B2 |
9566152 | Schweich et al. | Feb 2017 | B2 |
9597182 | Straubinger | Mar 2017 | B2 |
9629716 | Seguin | Apr 2017 | B2 |
9662203 | Sheahan et al. | May 2017 | B2 |
9681952 | Hacohen et al. | Jun 2017 | B2 |
9717591 | Chau et al. | Aug 2017 | B2 |
9743932 | Amplatz et al. | Aug 2017 | B2 |
9763657 | Hacohen et al. | Sep 2017 | B2 |
9763817 | Roeder | Sep 2017 | B2 |
9770256 | Cohen et al. | Sep 2017 | B2 |
D800908 | Hariton et al. | Oct 2017 | S |
9788941 | Hacohen | Oct 2017 | B2 |
9895226 | Harari et al. | Feb 2018 | B1 |
9987132 | Hariton et al. | Jun 2018 | B1 |
10010414 | Cooper et al. | Jul 2018 | B2 |
10076415 | Metchik et al. | Sep 2018 | B1 |
10105222 | Metchik et al. | Oct 2018 | B1 |
10111751 | Metchik et al. | Oct 2018 | B1 |
10123873 | Metchik et al. | Nov 2018 | B1 |
10130475 | Metchik et al. | Nov 2018 | B1 |
10136993 | Metchik et al. | Nov 2018 | B1 |
10143552 | Wallace et al. | Dec 2018 | B2 |
10149761 | Granada et al. | Dec 2018 | B2 |
10154903 | Albitov et al. | Dec 2018 | B2 |
10154906 | Granada et al. | Dec 2018 | B2 |
10159570 | Metchik et al. | Dec 2018 | B1 |
10182908 | Tubishevitz et al. | Jan 2019 | B2 |
10226341 | Gross et al. | Mar 2019 | B2 |
10231837 | Metchik et al. | Mar 2019 | B1 |
10238493 | Metchik et al. | Mar 2019 | B1 |
10245143 | Gross et al. | Apr 2019 | B2 |
10245144 | Metchik et al. | Apr 2019 | B1 |
10258471 | Lutter et al. | Apr 2019 | B2 |
10299927 | McLean | May 2019 | B2 |
10321995 | Christianson et al. | Jun 2019 | B1 |
10322020 | Lam et al. | Jun 2019 | B2 |
10327895 | Lozonschi et al. | Jun 2019 | B2 |
10335278 | McLean | Jul 2019 | B2 |
10376361 | Gross et al. | Aug 2019 | B2 |
10426614 | Hariton et al. | Oct 2019 | B2 |
10507108 | Delgado et al. | Dec 2019 | B2 |
10507109 | Metchik et al. | Dec 2019 | B2 |
10512456 | Hacohen | Dec 2019 | B2 |
10517719 | Miller | Dec 2019 | B2 |
10524792 | Hernandez et al. | Jan 2020 | B2 |
10531866 | Hariton et al. | Jan 2020 | B2 |
10531872 | Hacohen et al. | Jan 2020 | B2 |
10548731 | Lashinski et al. | Feb 2020 | B2 |
10575948 | Iamberger et al. | Mar 2020 | B2 |
10595992 | Chambers | Mar 2020 | B2 |
10595997 | Metchik et al. | Mar 2020 | B2 |
10610358 | Vidlund | Apr 2020 | B2 |
10646342 | Marr et al. | May 2020 | B1 |
10702385 | Hacohen | Jul 2020 | B2 |
10758342 | Chau | Sep 2020 | B2 |
10813760 | Metchik et al. | Oct 2020 | B2 |
10820998 | Marr et al. | Nov 2020 | B2 |
10842627 | Delgado | Nov 2020 | B2 |
10856975 | Hariton | Dec 2020 | B2 |
10856978 | Straubinger | Dec 2020 | B2 |
10874514 | Dixon | Dec 2020 | B2 |
10888644 | Ratz | Jan 2021 | B2 |
10905552 | Dixon | Feb 2021 | B2 |
10905554 | Cao | Feb 2021 | B2 |
10918483 | Metchik | Feb 2021 | B2 |
10945844 | Mccann | Mar 2021 | B2 |
10993809 | Mccann | May 2021 | B2 |
11083582 | Mccann | Aug 2021 | B2 |
11147672 | Mccann | Oct 2021 | B2 |
20010002445 | Vesely | May 2001 | A1 |
20010005787 | Oz | Jun 2001 | A1 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20010056295 | Solem | Dec 2001 | A1 |
20020013571 | Goldfarb et al. | Jan 2002 | A1 |
20020032481 | Gabbay | Mar 2002 | A1 |
20020099436 | Thornton et al. | Jul 2002 | A1 |
20020151970 | Garrison et al. | Oct 2002 | A1 |
20020177894 | Acosta et al. | Nov 2002 | A1 |
20030036791 | Bonhoeffer et al. | Feb 2003 | A1 |
20030050694 | Yang | Mar 2003 | A1 |
20030060875 | Wittens | Mar 2003 | A1 |
20030069635 | Cartledge | Apr 2003 | A1 |
20030074052 | Besselink | Apr 2003 | A1 |
20030083742 | Spence et al. | May 2003 | A1 |
20030105519 | Fasol et al. | Jun 2003 | A1 |
20030158578 | Pantages et al. | Aug 2003 | A1 |
20040010272 | Manetakis et al. | Jan 2004 | A1 |
20040030382 | St. Goar et al. | Feb 2004 | A1 |
20040039414 | Carley et al. | Feb 2004 | A1 |
20040093060 | Seguin et al. | May 2004 | A1 |
20040122503 | Campbell et al. | Jun 2004 | A1 |
20040122514 | Fogarty et al. | Jun 2004 | A1 |
20040133267 | Lane | Jul 2004 | A1 |
20040143315 | Bruun et al. | Jul 2004 | A1 |
20040176839 | Huynh et al. | Sep 2004 | A1 |
20040186558 | Pavcnik et al. | Sep 2004 | A1 |
20040186565 | Schreck | Sep 2004 | A1 |
20040186566 | Hindrichs et al. | Sep 2004 | A1 |
20040210244 | Vargas et al. | Oct 2004 | A1 |
20040210304 | Seguin et al. | Oct 2004 | A1 |
20040220593 | Greenhalgh | Nov 2004 | A1 |
20040225354 | Allen et al. | Nov 2004 | A1 |
20040236354 | Seguin | Nov 2004 | A1 |
20040249433 | Freitag | Dec 2004 | A1 |
20040260389 | Case et al. | Dec 2004 | A1 |
20040260394 | Douk et al. | Dec 2004 | A1 |
20050004668 | Aklog et al. | Jan 2005 | A1 |
20050021056 | St. Goar et al. | Jan 2005 | A1 |
20050027305 | Shiu et al. | Feb 2005 | A1 |
20050027348 | Case et al. | Feb 2005 | A1 |
20050038494 | Eidenschink | Feb 2005 | A1 |
20050055086 | Stobie | Mar 2005 | A1 |
20050075731 | Artof et al. | Apr 2005 | A1 |
20050080430 | Wright et al. | Apr 2005 | A1 |
20050080474 | Andreas | Apr 2005 | A1 |
20050085900 | Case et al. | Apr 2005 | A1 |
20050137686 | Salahieh et al. | Jun 2005 | A1 |
20050137688 | Salahieh et al. | Jun 2005 | A1 |
20050137689 | Salahieh et al. | Jun 2005 | A1 |
20050137690 | Salahieh et al. | Jun 2005 | A1 |
20050137691 | Salahieh | Jun 2005 | A1 |
20050137692 | Haug et al. | Jun 2005 | A1 |
20050137695 | Salahieh et al. | Jun 2005 | A1 |
20050137697 | Salahieh et al. | Jun 2005 | A1 |
20050143809 | Salahieh et al. | Jun 2005 | A1 |
20050149160 | McFerran | Jul 2005 | A1 |
20050154443 | Linder et al. | Jul 2005 | A1 |
20050182483 | Osborne et al. | Aug 2005 | A1 |
20050182486 | Gabbay | Aug 2005 | A1 |
20050197695 | Stacchino et al. | Sep 2005 | A1 |
20050203549 | Realyvasquez | Sep 2005 | A1 |
20050203618 | Sharkawy et al. | Sep 2005 | A1 |
20050216079 | MaCoviak | Sep 2005 | A1 |
20050234508 | Cummins et al. | Oct 2005 | A1 |
20050240200 | Bergheim | Oct 2005 | A1 |
20050251251 | Cribier | Nov 2005 | A1 |
20050256566 | Gabbay | Nov 2005 | A1 |
20050267573 | Macoviak et al. | Dec 2005 | A9 |
20060004439 | Spenser et al. | Jan 2006 | A1 |
20060004469 | Sokel | Jan 2006 | A1 |
20060015171 | Armstrong | Jan 2006 | A1 |
20060020275 | Goldfarb et al. | Jan 2006 | A1 |
20060020327 | Lashinski et al. | Jan 2006 | A1 |
20060020333 | Lashinski et al. | Jan 2006 | A1 |
20060041189 | Vancaillie | Feb 2006 | A1 |
20060052867 | Revuelta et al. | Mar 2006 | A1 |
20060089627 | Burnett et al. | Apr 2006 | A1 |
20060111773 | Rittgers et al. | May 2006 | A1 |
20060116750 | Herbert et al. | Jun 2006 | A1 |
20060135964 | Vesley | Jun 2006 | A1 |
20060155357 | Melsheimer | Jul 2006 | A1 |
20060161250 | Shaw | Jul 2006 | A1 |
20060047297 | Case | Aug 2006 | A1 |
20060178700 | Quinn | Aug 2006 | A1 |
20060178740 | Stacchino et al. | Aug 2006 | A1 |
20060184203 | Martin et al. | Aug 2006 | A1 |
20060190036 | Wendel et al. | Aug 2006 | A1 |
20060190038 | Carley et al. | Aug 2006 | A1 |
20060195183 | Navia et al. | Aug 2006 | A1 |
20060195184 | Lane et al. | Aug 2006 | A1 |
20060201519 | Frazier et al. | Sep 2006 | A1 |
20060212111 | Case et al. | Sep 2006 | A1 |
20060216404 | Seyler | Sep 2006 | A1 |
20060229708 | Powell et al. | Oct 2006 | A1 |
20060241656 | Starksen et al. | Oct 2006 | A1 |
20060241745 | Solem | Oct 2006 | A1 |
20060241748 | Lee et al. | Oct 2006 | A1 |
20060247680 | Amplatz et al. | Nov 2006 | A1 |
20060253191 | Salahieh et al. | Nov 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060271166 | Thill et al. | Nov 2006 | A1 |
20060271171 | McQuinn et al. | Nov 2006 | A1 |
20060282150 | Olson et al. | Dec 2006 | A1 |
20060287719 | Rowe et al. | Dec 2006 | A1 |
20070016286 | Herrmann | Jan 2007 | A1 |
20070016288 | Gurskis et al. | Jan 2007 | A1 |
20070027528 | Agnew | Feb 2007 | A1 |
20070027549 | Godin | Feb 2007 | A1 |
20070038293 | St. Goar et al. | Feb 2007 | A1 |
20070038295 | Case et al. | Feb 2007 | A1 |
20070043435 | Seguin et al. | Feb 2007 | A1 |
20070055340 | Pryor | Mar 2007 | A1 |
20070056346 | Spenser et al. | Mar 2007 | A1 |
20070078510 | Ryan | Apr 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070118151 | Davidson | May 2007 | A1 |
20070162103 | Case et al. | Jul 2007 | A1 |
20070162107 | Haug et al. | Jul 2007 | A1 |
20070162111 | Fukamachi et al. | Jul 2007 | A1 |
20070173932 | Cali et al. | Jul 2007 | A1 |
20070197858 | Goldfarb et al. | Aug 2007 | A1 |
20070198077 | Cully et al. | Aug 2007 | A1 |
20070198097 | Zegdi | Aug 2007 | A1 |
20070213810 | Newhauser et al. | Sep 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070219630 | Chu | Sep 2007 | A1 |
20070225759 | Thommen et al. | Sep 2007 | A1 |
20070225760 | Moszner et al. | Sep 2007 | A1 |
20070233186 | Meng | Oct 2007 | A1 |
20070233237 | Krivoruchko | Oct 2007 | A1 |
20070239272 | Navia et al. | Oct 2007 | A1 |
20070239273 | Allen | Oct 2007 | A1 |
20070244546 | Francis | Oct 2007 | A1 |
20070255400 | Parravicini et al. | Nov 2007 | A1 |
20080004688 | Spenser et al. | Jan 2008 | A1 |
20080004697 | Lichtenstein et al. | Jan 2008 | A1 |
20080051703 | Thornton et al. | Feb 2008 | A1 |
20080071361 | Tuval et al. | Mar 2008 | A1 |
20080071363 | Tuval et al. | Mar 2008 | A1 |
20080071366 | Tuval et al. | Mar 2008 | A1 |
20080071369 | Tuval et al. | Mar 2008 | A1 |
20080077235 | Kirson | Mar 2008 | A1 |
20080082083 | Forde et al. | Apr 2008 | A1 |
20080082159 | Tseng et al. | Apr 2008 | A1 |
20080082166 | Styrc et al. | Apr 2008 | A1 |
20080086164 | Rowe et al. | Apr 2008 | A1 |
20080086204 | Rankin | Apr 2008 | A1 |
20080091261 | Long et al. | Apr 2008 | A1 |
20080097595 | Gabbay | Apr 2008 | A1 |
20080132989 | Snow et al. | Jun 2008 | A1 |
20080140003 | Bei et al. | Jun 2008 | A1 |
20080147182 | Righini et al. | Jun 2008 | A1 |
20080161910 | Revuelta et al. | Jul 2008 | A1 |
20080167705 | Agnew | Jul 2008 | A1 |
20080167714 | St. Goar et al. | Jul 2008 | A1 |
20080188929 | Schreck | Aug 2008 | A1 |
20080195200 | Vidlund et al. | Aug 2008 | A1 |
20080200980 | Robin et al. | Aug 2008 | A1 |
20080208328 | Antocci | Aug 2008 | A1 |
20080208332 | Lamphere et al. | Aug 2008 | A1 |
20080221672 | Lamphere et al. | Sep 2008 | A1 |
20080234814 | Salahieh et al. | Sep 2008 | A1 |
20080243245 | Thambar et al. | Oct 2008 | A1 |
20080255580 | Hoffman et al. | Oct 2008 | A1 |
20080262609 | Gross et al. | Oct 2008 | A1 |
20080269879 | Sathe et al. | Oct 2008 | A1 |
20080281411 | Berreklouw | Nov 2008 | A1 |
20080294234 | Hartley et al. | Nov 2008 | A1 |
20090005863 | Goetz et al. | Jan 2009 | A1 |
20090036966 | O'Connor et al. | Feb 2009 | A1 |
20090054969 | Salahieh et al. | Feb 2009 | A1 |
20090088836 | Bishop et al. | Apr 2009 | A1 |
20090099554 | Forster et al. | Apr 2009 | A1 |
20090099650 | Bolduc et al. | Apr 2009 | A1 |
20090112159 | Slattery et al. | Apr 2009 | A1 |
20090125098 | Chuter | May 2009 | A1 |
20090157175 | Benichou | Jun 2009 | A1 |
20090171363 | Chocron | Jul 2009 | A1 |
20090177278 | Spence | Jul 2009 | A1 |
20090210052 | Forster et al. | Aug 2009 | A1 |
20090222081 | Linder et al. | Sep 2009 | A1 |
20090240320 | Tuval et al. | Sep 2009 | A1 |
20090248143 | Laham | Oct 2009 | A1 |
20090259306 | Rowe | Oct 2009 | A1 |
20090264859 | Mas | Oct 2009 | A1 |
20090264994 | Saadat | Oct 2009 | A1 |
20090276040 | Rowe et al. | Nov 2009 | A1 |
20090281619 | Le et al. | Nov 2009 | A1 |
20090287304 | Dahlgren et al. | Nov 2009 | A1 |
20090299449 | Styrc | Dec 2009 | A1 |
20090306768 | Quardi | Dec 2009 | A1 |
20090319037 | Rowe et al. | Dec 2009 | A1 |
20100022823 | Goldfarb | Jan 2010 | A1 |
20100023117 | Yoganathan et al. | Jan 2010 | A1 |
20100023120 | Holecek et al. | Jan 2010 | A1 |
20100036479 | Hill et al. | Feb 2010 | A1 |
20100049313 | Alon et al. | Feb 2010 | A1 |
20100069852 | Kelley | Mar 2010 | A1 |
20100076548 | Konno | Mar 2010 | A1 |
20100100167 | Bortlein | Apr 2010 | A1 |
20100114299 | Ben Muvhar et al. | May 2010 | A1 |
20100131054 | Tuval et al. | May 2010 | A1 |
20100137979 | Tuval et al. | Jun 2010 | A1 |
20100160958 | Clark | Jun 2010 | A1 |
20100161036 | Pintor et al. | Jun 2010 | A1 |
20100161042 | Maisano et al. | Jun 2010 | A1 |
20100174363 | Castro | Jul 2010 | A1 |
20100179643 | Shalev | Jul 2010 | A1 |
20100179648 | Richter et al. | Jul 2010 | A1 |
20100179649 | Richter et al. | Jul 2010 | A1 |
20100217382 | Chau et al. | Aug 2010 | A1 |
20100222810 | DeBeer et al. | Sep 2010 | A1 |
20100228285 | Miles et al. | Sep 2010 | A1 |
20100234940 | Dolan | Sep 2010 | A1 |
20100249908 | Chau et al. | Sep 2010 | A1 |
20100249917 | Zhang | Sep 2010 | A1 |
20100256737 | Pollock et al. | Oct 2010 | A1 |
20100262232 | Annest | Oct 2010 | A1 |
20100280603 | Maisano et al. | Nov 2010 | A1 |
20100280606 | Naor | Nov 2010 | A1 |
20100312333 | Navia et al. | Dec 2010 | A1 |
20100324595 | Linder et al. | Dec 2010 | A1 |
20100331971 | Keränen et al. | Dec 2010 | A1 |
20110004227 | Goldfarb et al. | Jan 2011 | A1 |
20110004296 | Lutter et al. | Jan 2011 | A1 |
20110004299 | Navia et al. | Jan 2011 | A1 |
20110015729 | Jimenez et al. | Jan 2011 | A1 |
20110015731 | Carpentier et al. | Jan 2011 | A1 |
20110021985 | Spargias | Jan 2011 | A1 |
20110022165 | Oba et al. | Jan 2011 | A1 |
20110178597 | Navia et al. | Jan 2011 | A9 |
20110029072 | Gabbay | Feb 2011 | A1 |
20110040374 | Goetz et al. | Feb 2011 | A1 |
20110040375 | Letac et al. | Feb 2011 | A1 |
20110046662 | Moszner et al. | Feb 2011 | A1 |
20110054466 | Rothstein et al. | Mar 2011 | A1 |
20110054596 | Taylor | Mar 2011 | A1 |
20110054598 | Johnson | Mar 2011 | A1 |
20110066233 | Thornton et al. | Mar 2011 | A1 |
20110071626 | Wright et al. | Mar 2011 | A1 |
20110077730 | Fentster | Mar 2011 | A1 |
20110082538 | Dahlgren et al. | Apr 2011 | A1 |
20110087322 | Letac et al. | Apr 2011 | A1 |
20110093063 | Schreck | Apr 2011 | A1 |
20110098525 | Kermode et al. | Apr 2011 | A1 |
20110106247 | Miller et al. | May 2011 | A1 |
20110112625 | Ben-Muvhar et al. | May 2011 | A1 |
20110112632 | Chau et al. | May 2011 | A1 |
20110113768 | Bauer et al. | May 2011 | A1 |
20110118830 | Liddicoat et al. | May 2011 | A1 |
20110125257 | Seguin et al. | May 2011 | A1 |
20110125258 | Centola | May 2011 | A1 |
20110137326 | Bachman | Jun 2011 | A1 |
20110137397 | Chau et al. | Jun 2011 | A1 |
20110137409 | Yang et al. | Jun 2011 | A1 |
20110137410 | Hacohen | Jun 2011 | A1 |
20110144742 | Madrid et al. | Jun 2011 | A1 |
20110166636 | Rowe | Jul 2011 | A1 |
20110172784 | Richter | Jul 2011 | A1 |
20110184510 | Maisano et al. | Jul 2011 | A1 |
20110190877 | Lane et al. | Aug 2011 | A1 |
20110190879 | Bobo et al. | Aug 2011 | A1 |
20110202076 | Richter | Aug 2011 | A1 |
20110208283 | Rust | Aug 2011 | A1 |
20110208293 | Tabor | Aug 2011 | A1 |
20110208298 | Tuval et al. | Aug 2011 | A1 |
20110213459 | Garrison et al. | Sep 2011 | A1 |
20110213461 | Seguin et al. | Sep 2011 | A1 |
20110218619 | Benichou et al. | Sep 2011 | A1 |
20110218620 | Meiri et al. | Sep 2011 | A1 |
20110224785 | Hacohen | Sep 2011 | A1 |
20110238159 | Guyenot et al. | Sep 2011 | A1 |
20110245911 | Quill et al. | Oct 2011 | A1 |
20110245917 | Savage et al. | Oct 2011 | A1 |
20110251675 | Dwork | Oct 2011 | A1 |
20110251676 | Sweeney et al. | Oct 2011 | A1 |
20110251678 | Eidenschink et al. | Oct 2011 | A1 |
20110251679 | Wiemeyer et al. | Oct 2011 | A1 |
20110251680 | Tran et al. | Oct 2011 | A1 |
20110251682 | Murray, III et al. | Oct 2011 | A1 |
20110251683 | Tabor | Oct 2011 | A1 |
20110257721 | Tabor | Oct 2011 | A1 |
20110257729 | Spenser et al. | Oct 2011 | A1 |
20110257736 | Marquez et al. | Oct 2011 | A1 |
20110257737 | Fogarty et al. | Oct 2011 | A1 |
20110264191 | Rothstein | Oct 2011 | A1 |
20110264196 | Savage et al. | Oct 2011 | A1 |
20110264198 | Murray, III et al. | Oct 2011 | A1 |
20110264199 | Tran et al. | Oct 2011 | A1 |
20110264200 | Tran et al. | Oct 2011 | A1 |
20110264201 | Yeung et al. | Oct 2011 | A1 |
20110264202 | Murray, III et al. | Oct 2011 | A1 |
20110264203 | Dwork et al. | Oct 2011 | A1 |
20110264206 | Tabor | Oct 2011 | A1 |
20110264208 | Duffy | Oct 2011 | A1 |
20110270276 | Rothstein et al. | Nov 2011 | A1 |
20110271967 | Mortier et al. | Nov 2011 | A1 |
20110282438 | Drews et al. | Nov 2011 | A1 |
20110282439 | Thill et al. | Nov 2011 | A1 |
20110282440 | Cao | Nov 2011 | A1 |
20110283514 | Fogarty et al. | Nov 2011 | A1 |
20110288632 | White | Nov 2011 | A1 |
20110288634 | Tuval et al. | Nov 2011 | A1 |
20110295354 | Bueche et al. | Dec 2011 | A1 |
20110295363 | Girard et al. | Dec 2011 | A1 |
20110301688 | Dolan | Dec 2011 | A1 |
20110301698 | Miller et al. | Dec 2011 | A1 |
20110301701 | Padala et al. | Dec 2011 | A1 |
20110301702 | Rust et al. | Dec 2011 | A1 |
20110306916 | Nitzan et al. | Dec 2011 | A1 |
20110307049 | Kao | Dec 2011 | A1 |
20110313452 | Carley et al. | Dec 2011 | A1 |
20110313515 | Quadri et al. | Dec 2011 | A1 |
20110319989 | Lane et al. | Dec 2011 | A1 |
20110319991 | Hariton et al. | Dec 2011 | A1 |
20120010694 | Lutter et al. | Jan 2012 | A1 |
20120016468 | Robin et al. | Jan 2012 | A1 |
20120022629 | Perera et al. | Jan 2012 | A1 |
20120022633 | Olson et al. | Jan 2012 | A1 |
20120022637 | Ben-Muvhar et al. | Jan 2012 | A1 |
20120022639 | Hacohen et al. | Jan 2012 | A1 |
20120022640 | Gross et al. | Jan 2012 | A1 |
20120035703 | Lutter et al. | Feb 2012 | A1 |
20120035713 | Lutter et al. | Feb 2012 | A1 |
20120035722 | Tuval et al. | Feb 2012 | A1 |
20120041547 | Duffy et al. | Feb 2012 | A1 |
20120041551 | Spenser et al. | Feb 2012 | A1 |
20120046738 | Lau et al. | Feb 2012 | A1 |
20120046742 | Tuval et al. | Feb 2012 | A1 |
20120053676 | Ku et al. | Mar 2012 | A1 |
20120053682 | Kovalsky et al. | Mar 2012 | A1 |
20120053688 | Fogarty et al. | Mar 2012 | A1 |
20120059337 | Eilat | Mar 2012 | A1 |
20120059454 | Millwee et al. | Mar 2012 | A1 |
20120059458 | Buchbinder et al. | Mar 2012 | A1 |
20120065464 | Ellis et al. | Mar 2012 | A1 |
20120078237 | Wang et al. | Mar 2012 | A1 |
20120078353 | Quadri et al. | Mar 2012 | A1 |
20120078357 | Conklin | Mar 2012 | A1 |
20120083832 | Delaloye et al. | Apr 2012 | A1 |
20120083839 | Letac et al. | Apr 2012 | A1 |
20120083879 | Eberhardt et al. | Apr 2012 | A1 |
20120089223 | Nguyen et al. | Apr 2012 | A1 |
20120101570 | Tuval et al. | Apr 2012 | A1 |
20120101571 | Thambar et al. | Apr 2012 | A1 |
20120101572 | Kovalsky et al. | Apr 2012 | A1 |
20120123511 | Brown | May 2012 | A1 |
20120123530 | Carpentier et al. | May 2012 | A1 |
20120130473 | Norris et al. | May 2012 | A1 |
20120130474 | Buckley | May 2012 | A1 |
20120130475 | Shaw | May 2012 | A1 |
20120136434 | Carpentier et al. | May 2012 | A1 |
20120150218 | Sandgren et al. | Jun 2012 | A1 |
20120165915 | Melsheimer et al. | Jun 2012 | A1 |
20120165930 | Gifford, III | Jun 2012 | A1 |
20120179244 | Schankereli et al. | Jul 2012 | A1 |
20120197292 | Chin-Chen et al. | Aug 2012 | A1 |
20120283824 | Lutter et al. | Nov 2012 | A1 |
20120290062 | McNamara et al. | Nov 2012 | A1 |
20120296360 | Norris et al. | Nov 2012 | A1 |
20120296418 | Bonyuet et al. | Nov 2012 | A1 |
20120300063 | Majkrzak et al. | Nov 2012 | A1 |
20120310328 | Olson et al. | Dec 2012 | A1 |
20120323316 | Chau et al. | Dec 2012 | A1 |
20120330408 | Hillukka et al. | Dec 2012 | A1 |
20130006347 | McHugo | Jan 2013 | A1 |
20130018450 | Hunt | Jan 2013 | A1 |
20130018458 | Yohanan et al. | Jan 2013 | A1 |
20130035759 | Gross et al. | Feb 2013 | A1 |
20130041204 | Heilman et al. | Feb 2013 | A1 |
20130041451 | Patterson et al. | Feb 2013 | A1 |
20130046373 | Cartledge et al. | Feb 2013 | A1 |
20130066342 | Dell | Mar 2013 | A1 |
20130079872 | Gallagher | Mar 2013 | A1 |
20130116780 | Miller et al. | May 2013 | A1 |
20130123896 | Bloss et al. | May 2013 | A1 |
20130123900 | Eblacas et al. | May 2013 | A1 |
20130150945 | Crawford et al. | Jun 2013 | A1 |
20130150956 | Yohanan et al. | Jun 2013 | A1 |
20130158647 | Norris et al. | Jun 2013 | A1 |
20130166017 | Cartledge et al. | Jun 2013 | A1 |
20130166022 | Conklin | Jun 2013 | A1 |
20130172978 | Vidlund et al. | Jul 2013 | A1 |
20130172992 | Gross et al. | Jul 2013 | A1 |
20130178930 | Straubinger | Jul 2013 | A1 |
20130190861 | Chau et al. | Jul 2013 | A1 |
20130211501 | Buckley et al. | Aug 2013 | A1 |
20130231735 | Deem et al. | Sep 2013 | A1 |
20130245742 | Norris | Sep 2013 | A1 |
20130253634 | Wilson | Sep 2013 | A1 |
20130253643 | Rolando | Sep 2013 | A1 |
20130261737 | Costello | Oct 2013 | A1 |
20130261738 | Clague et al. | Oct 2013 | A1 |
20130274870 | Lombardi et al. | Oct 2013 | A1 |
20130282059 | Ketai et al. | Oct 2013 | A1 |
20130289711 | Liddy et al. | Oct 2013 | A1 |
20130289740 | Liddy et al. | Oct 2013 | A1 |
20130297013 | Klima et al. | Nov 2013 | A1 |
20130304197 | Buchbinder et al. | Nov 2013 | A1 |
20130304200 | McLean et al. | Nov 2013 | A1 |
20130310928 | Morriss et al. | Nov 2013 | A1 |
20130325114 | McLean et al. | Dec 2013 | A1 |
20130331929 | Mitra et al. | Dec 2013 | A1 |
20140000112 | Braido et al. | Jan 2014 | A1 |
20140005778 | Buchbinder et al. | Jan 2014 | A1 |
20140018911 | Zhou et al. | Jan 2014 | A1 |
20140018915 | Biadillah et al. | Jan 2014 | A1 |
20140031928 | Murphy et al. | Jan 2014 | A1 |
20140046430 | Shaw | Feb 2014 | A1 |
20140052237 | Lane et al. | Feb 2014 | A1 |
20140067050 | Costello et al. | Mar 2014 | A1 |
20140067054 | Chau et al. | Mar 2014 | A1 |
20140081376 | Burkart et al. | Mar 2014 | A1 |
20140106951 | Brandon | Apr 2014 | A1 |
20140120287 | Jacoby et al. | May 2014 | A1 |
20140121749 | Roeder | May 2014 | A1 |
20140121763 | Duffy et al. | May 2014 | A1 |
20140135894 | Norris et al. | May 2014 | A1 |
20140135895 | Andress et al. | May 2014 | A1 |
20140142681 | Norris | May 2014 | A1 |
20140142688 | Duffy et al. | May 2014 | A1 |
20140148891 | Johnson | May 2014 | A1 |
20140163690 | White | Jun 2014 | A1 |
20140172069 | Roeder et al. | Jun 2014 | A1 |
20140172077 | Bruchman et al. | Jun 2014 | A1 |
20140172082 | Bruchman et al. | Jun 2014 | A1 |
20140188210 | Beard et al. | Jul 2014 | A1 |
20140188221 | Chung et al. | Jul 2014 | A1 |
20140194981 | Menk et al. | Jul 2014 | A1 |
20140194983 | Kovalsky et al. | Jul 2014 | A1 |
20140207231 | Hacohen et al. | Jul 2014 | A1 |
20140214159 | Vidlund et al. | Jul 2014 | A1 |
20140222136 | Geist et al. | Aug 2014 | A1 |
20140222142 | Kovalsky et al. | Aug 2014 | A1 |
20140236287 | Clague et al. | Aug 2014 | A1 |
20140236289 | Alkhatib | Aug 2014 | A1 |
20140249622 | Carmi et al. | Sep 2014 | A1 |
20140257461 | Robinson et al. | Sep 2014 | A1 |
20140257467 | Lane et al. | Sep 2014 | A1 |
20140257475 | Gross et al. | Sep 2014 | A1 |
20140257476 | Montorfano et al. | Sep 2014 | A1 |
20140277358 | Slazas | Sep 2014 | A1 |
20140277409 | Börtlein et al. | Sep 2014 | A1 |
20140277411 | Börtlein et al. | Sep 2014 | A1 |
20140277418 | Miller | Sep 2014 | A1 |
20140277422 | Ratz et al. | Sep 2014 | A1 |
20140277427 | Ratz et al. | Sep 2014 | A1 |
20140296962 | Cartledge et al. | Oct 2014 | A1 |
20140296969 | Tegels et al. | Oct 2014 | A1 |
20140324164 | Gross et al. | Oct 2014 | A1 |
20140336744 | Tani et al. | Nov 2014 | A1 |
20140343670 | Bakis et al. | Nov 2014 | A1 |
20140358222 | Gorman, III et al. | Dec 2014 | A1 |
20140358224 | Tegels et al. | Dec 2014 | A1 |
20140379065 | Johnson et al. | Dec 2014 | A1 |
20140379074 | Spence et al. | Dec 2014 | A1 |
20140379076 | Vidlund et al. | Dec 2014 | A1 |
20150018944 | O'Connor et al. | Jan 2015 | A1 |
20150032205 | Matheny | Jan 2015 | A1 |
20150045880 | Hacohen | Feb 2015 | A1 |
20150045881 | Lim | Feb 2015 | A1 |
20150094802 | Buchbinder et al. | Apr 2015 | A1 |
20150119970 | Nakayama et al. | Apr 2015 | A1 |
20150127097 | Neumann et al. | May 2015 | A1 |
20150142100 | Morriss et al. | May 2015 | A1 |
20150142103 | Vidlund | May 2015 | A1 |
20150148894 | Damm et al. | May 2015 | A1 |
20150157457 | Hacohen | Jun 2015 | A1 |
20150157458 | Thambar et al. | Jun 2015 | A1 |
20150173896 | Richter et al. | Jun 2015 | A1 |
20150173897 | Raanani | Jun 2015 | A1 |
20150196390 | Ma | Jul 2015 | A1 |
20150196393 | Vidlund et al. | Jul 2015 | A1 |
20150216661 | Hacohen et al. | Aug 2015 | A1 |
20150238313 | Spence et al. | Aug 2015 | A1 |
20150245934 | Lombardi et al. | Sep 2015 | A1 |
20150250588 | Yang | Sep 2015 | A1 |
20150272730 | Melnick et al. | Oct 2015 | A1 |
20150272731 | Racchini | Oct 2015 | A1 |
20150272734 | Sheps et al. | Oct 2015 | A1 |
20150282964 | Beard et al. | Oct 2015 | A1 |
20150320556 | Levi et al. | Nov 2015 | A1 |
20150327994 | Morriss et al. | Nov 2015 | A1 |
20150328000 | Ratz et al. | Nov 2015 | A1 |
20150335429 | Morriss et al. | Nov 2015 | A1 |
20150342736 | Rabito et al. | Dec 2015 | A1 |
20150351903 | Morriss et al. | Dec 2015 | A1 |
20150351904 | Cooper et al. | Dec 2015 | A1 |
20150351906 | Hammer et al. | Dec 2015 | A1 |
20150359629 | Ganesan et al. | Dec 2015 | A1 |
20160030169 | Shahriari | Feb 2016 | A1 |
20160030171 | Quijano et al. | Feb 2016 | A1 |
20160089482 | Siegenthaler | Mar 2016 | A1 |
20160095700 | Righini | Apr 2016 | A1 |
20160100939 | Armstrong et al. | Apr 2016 | A1 |
20160106539 | Buchbinder et al. | Apr 2016 | A1 |
20160113766 | Ganesan et al. | Apr 2016 | A1 |
20160113768 | Ganesan et al. | Apr 2016 | A1 |
20160125160 | Heneghan et al. | May 2016 | A1 |
20160175095 | Dienno et al. | Jun 2016 | A1 |
20160213473 | Hacohen et al. | Jul 2016 | A1 |
20160220367 | Barrett | Aug 2016 | A1 |
20160228247 | Maimon et al. | Aug 2016 | A1 |
20160242902 | Morriss et al. | Aug 2016 | A1 |
20160270911 | Ganesan et al. | Sep 2016 | A1 |
20160296330 | Hacohen | Oct 2016 | A1 |
20160310268 | Oba | Oct 2016 | A1 |
20160310274 | Gross et al. | Oct 2016 | A1 |
20160317301 | Quadri et al. | Nov 2016 | A1 |
20160317305 | Pelled et al. | Nov 2016 | A1 |
20160324633 | Gross et al. | Nov 2016 | A1 |
20160324635 | Vidlund et al. | Nov 2016 | A1 |
20160324640 | Gifford et al. | Nov 2016 | A1 |
20160331526 | Schweich et al. | Nov 2016 | A1 |
20160331527 | Vidlund et al. | Nov 2016 | A1 |
20160338706 | Rowe | Nov 2016 | A1 |
20160367360 | Cartledge et al. | Dec 2016 | A1 |
20160367368 | Vidlund et al. | Dec 2016 | A1 |
20160374801 | Jimenez et al. | Dec 2016 | A1 |
20160374802 | Levi et al. | Dec 2016 | A1 |
20170042678 | Ganesan et al. | Feb 2017 | A1 |
20170049435 | Sauer | Feb 2017 | A1 |
20170056166 | Ratz et al. | Mar 2017 | A1 |
20170056171 | Cooper et al. | Mar 2017 | A1 |
20170065407 | Hacohen et al. | Mar 2017 | A1 |
20170065411 | Grundeman et al. | Mar 2017 | A1 |
20170128205 | Tamir et al. | May 2017 | A1 |
20170135816 | Lashinski et al. | May 2017 | A1 |
20170189174 | Braido et al. | Jul 2017 | A1 |
20170196688 | Christianson et al. | Jul 2017 | A1 |
20170196692 | Kirk et al. | Jul 2017 | A1 |
20170209264 | Chau et al. | Jul 2017 | A1 |
20170216026 | Quill et al. | Aug 2017 | A1 |
20170224323 | Rowe et al. | Aug 2017 | A1 |
20170231757 | Gassler | Aug 2017 | A1 |
20170231759 | Geist et al. | Aug 2017 | A1 |
20170231760 | Lane et al. | Aug 2017 | A1 |
20170239048 | Goldfarb et al. | Aug 2017 | A1 |
20170333183 | Backus | Nov 2017 | A1 |
20170333187 | Hariton et al. | Nov 2017 | A1 |
20180000580 | Wallace et al. | Jan 2018 | A1 |
20180021129 | Peterson et al. | Jan 2018 | A1 |
20180028215 | Cohen | Feb 2018 | A1 |
20180049873 | Manash et al. | Feb 2018 | A1 |
20180055628 | Patel et al. | Mar 2018 | A1 |
20180055630 | Patel et al. | Mar 2018 | A1 |
20180098850 | Rafiee | Apr 2018 | A1 |
20180116843 | Schreck | May 2018 | A1 |
20180125644 | Conklin | May 2018 | A1 |
20180153687 | Hariton et al. | Jun 2018 | A1 |
20180153689 | Maimon et al. | Jun 2018 | A1 |
20180153696 | Albitov et al. | Jun 2018 | A1 |
20180177593 | Hariton et al. | Jun 2018 | A1 |
20180177594 | Patel et al. | Jun 2018 | A1 |
20180185148 | Hariton et al. | Jul 2018 | A1 |
20180206983 | Noe et al. | Jul 2018 | A1 |
20180214263 | Rolando et al. | Aug 2018 | A1 |
20180250126 | O'connor et al. | Sep 2018 | A1 |
20180250147 | Syed | Sep 2018 | A1 |
20180296336 | Cooper et al. | Oct 2018 | A1 |
20180296341 | Noe et al. | Oct 2018 | A1 |
20180344457 | Gross et al. | Dec 2018 | A1 |
20180353294 | Calomeni et al. | Dec 2018 | A1 |
20180360457 | Ellis et al. | Dec 2018 | A1 |
20190053896 | Adamek-bowers et al. | Feb 2019 | A1 |
20190060060 | Chau et al. | Feb 2019 | A1 |
20190060068 | Cope et al. | Feb 2019 | A1 |
20190060070 | Groothuis et al. | Feb 2019 | A1 |
20190069997 | Ratz et al. | Mar 2019 | A1 |
20190105153 | Barash et al. | Apr 2019 | A1 |
20190117391 | Humair | Apr 2019 | A1 |
20190167423 | Hariton et al. | Jun 2019 | A1 |
20190175339 | Vidlund | Jun 2019 | A1 |
20190183639 | Moore | Jun 2019 | A1 |
20190192295 | Spence | Jun 2019 | A1 |
20190216602 | Lozonschi | Jul 2019 | A1 |
20190231525 | Hariton et al. | Aug 2019 | A1 |
20190336280 | Naor | Nov 2019 | A1 |
20190350701 | Adamek-bowers et al. | Nov 2019 | A1 |
20190365530 | Hoang et al. | Dec 2019 | A1 |
20190388218 | Vidlund et al. | Dec 2019 | A1 |
20190388220 | Vidlund et al. | Dec 2019 | A1 |
20200000449 | Goldfarb et al. | Jan 2020 | A1 |
20200000579 | Manash et al. | Jan 2020 | A1 |
20200015964 | Noe et al. | Jan 2020 | A1 |
20200030098 | Delgado et al. | Jan 2020 | A1 |
20200054335 | Hernandez et al. | Feb 2020 | A1 |
20200060818 | Geist et al. | Feb 2020 | A1 |
20200113677 | McCann et al. | Apr 2020 | A1 |
20200113689 | McCann et al. | Apr 2020 | A1 |
20200113692 | McCann et al. | Apr 2020 | A1 |
20200138567 | Marr et al. | May 2020 | A1 |
20200163761 | Hariton et al. | May 2020 | A1 |
20200214832 | Metchik et al. | Jul 2020 | A1 |
20200237512 | McCann et al. | Jul 2020 | A1 |
20200246136 | Marr et al. | Aug 2020 | A1 |
20200246140 | Hariton et al. | Aug 2020 | A1 |
20200253600 | Darabian | Aug 2020 | A1 |
20200261094 | Goldfarb et al. | Aug 2020 | A1 |
20200315786 | Metchik et al. | Oct 2020 | A1 |
20200337842 | Metchik et al. | Oct 2020 | A1 |
20210093449 | Hariton et al. | Apr 2021 | A1 |
20210113331 | Quadri | Apr 2021 | A1 |
Number | Date | Country |
---|---|---|
2822801 | Aug 2006 | CA |
103974674 | Aug 2014 | CN |
0170262 | Feb 1986 | EP |
1264582 | Dec 2002 | EP |
1637092 | Mar 2006 | EP |
1768630 | Jan 2015 | EP |
2349124 | Oct 2018 | EP |
3583922 | Dec 2019 | EP |
3270825 | Apr 2020 | EP |
2485795 | Sep 2020 | EP |
S53152790 | Dec 1978 | JP |
20010046894 | Jun 2001 | KR |
1998043557 | Oct 1998 | WO |
1999030647 | Jun 1999 | WO |
2000-047139 | Aug 2000 | WO |
2001-062189 | Aug 2001 | WO |
0182832 | Nov 2001 | WO |
2003020179 | Mar 2003 | WO |
2003028558 | Apr 2003 | WO |
2004028399 | Apr 2004 | WO |
2004108191 | Dec 2004 | WO |
2005107650 | Nov 2005 | WO |
2006007401 | Jan 2006 | WO |
2006007389 | Jan 2006 | WO |
06054930 | May 2006 | WO |
2006070372 | Jul 2006 | WO |
2006086434 | Aug 2006 | WO |
2006089236 | Aug 2006 | WO |
2006116558 | Nov 2006 | WO |
2006128193 | Nov 2006 | WO |
2007047488 | Apr 2007 | WO |
2007059252 | May 2007 | WO |
08013915 | Jan 2008 | WO |
2008029296 | Mar 2008 | WO |
2008031103 | Mar 2008 | WO |
2008070797 | Jun 2008 | WO |
2008103722 | Aug 2008 | WO |
09033469 | Mar 2009 | WO |
09053497 | Apr 2009 | WO |
2009091509 | Jul 2009 | WO |
2010006627 | Jan 2010 | WO |
2010027485 | Mar 2010 | WO |
2010037141 | Apr 2010 | WO |
2010045297 | Apr 2010 | WO |
2010057262 | May 2010 | WO |
2010073246 | Jul 2010 | WO |
2010081033 | Jul 2010 | WO |
2010121076 | Oct 2010 | WO |
2011025972 | Mar 2011 | WO |
2011069048 | Jun 2011 | WO |
2011089601 | Jul 2011 | WO |
2011106137 | Sep 2011 | WO |
2011111047 | Sep 2011 | WO |
0187190 | Nov 2011 | WO |
2011137531 | Nov 2011 | WO |
2011-143263 | Nov 2011 | WO |
2011144351 | Nov 2011 | WO |
2011154942 | Dec 2011 | WO |
2012011108 | Jan 2012 | WO |
2012024428 | Feb 2012 | WO |
2012036740 | Mar 2012 | WO |
2012048035 | Apr 2012 | WO |
2012127309 | Sep 2012 | WO |
2012177942 | Dec 2012 | WO |
2013021374 | Feb 2013 | WO |
2013021375 | Feb 2013 | WO |
2013021384 | Feb 2013 | WO |
2013059747 | Apr 2013 | WO |
2013072496 | May 2013 | WO |
2013078497 | Jun 2013 | WO |
2013114214 | Aug 2013 | WO |
2013128436 | Sep 2013 | WO |
2013175468 | Nov 2013 | WO |
2014022124 | Feb 2014 | WO |
2014076696 | May 2014 | WO |
2014115149 | Jul 2014 | WO |
2014121280 | Aug 2014 | WO |
2014145338 | Sep 2014 | WO |
2014144937 | Sep 2014 | WO |
2014164364 | Oct 2014 | WO |
2014194178 | Dec 2014 | WO |
2015173794 | Nov 2015 | WO |
2016016899 | Feb 2016 | WO |
2016093877 | Jun 2016 | WO |
2016125160 | Aug 2016 | WO |
2016125160 | Aug 2016 | WO |
2017223486 | Dec 2017 | WO |
2018025260 | Feb 2018 | WO |
2018025263 | Feb 2018 | WO |
2018029680 | Feb 2018 | WO |
2018039631 | Mar 2018 | WO |
2018106837 | Jun 2018 | WO |
2018108837 | Jun 2018 | WO |
2018112429 | Jun 2018 | WO |
2018118717 | Jun 2018 | WO |
2018131042 | Jul 2018 | WO |
2018131043 | Jul 2018 | WO |
2019026059 | Feb 2019 | WO |
2019030753 | Feb 2019 | WO |
2019027507 | Feb 2019 | WO |
2019077595 | Apr 2019 | WO |
2019116369 | Jun 2019 | WO |
2019138400 | Jul 2019 | WO |
2019195860 | Oct 2019 | WO |
2019202579 | Oct 2019 | WO |
2020058972 | Mar 2020 | WO |
2020167677 | Aug 2020 | WO |
Entry |
---|
An International Preliminary Report on Patentability dated Oct. 20, 2020, which issued during the prosecution of Applicant's PCT/IL2019/050142. |
An Office Action dated Oct. 5, 2020, which issued during the prosecution of Canadian Patent Application No. 2,973,940. |
Notice of Allowance dated Nov. 19, 2020, which issued during the prosecution of U.S. Appl. No. 16/318,025. |
An Office Action dated Sep. 24, 2020, which issued during the prosecution of U.S. Appl. No. 16/811,732. |
An Office Action summarized English translation and Search Report dated Nov. 25, 2020, which issued during the prosecution of Chinese Patent Application No. 201910449820.1. |
An Office Action dated Nov. 30, 2020, which issued during the prosecution of U.S. Appl. No. 16/138,129. |
Poirier, Nancy C., et al. “A novel repair for patients with atrioventricular septal defect requiring reoperation for left atrioventricular valve regurgitation.” European journal of cardio-thoracic surgery 18.1 (2000): 54-61. |
An Office Action dated Mar. 29, 2021, which issued during the prosecution of U.S. Appl. No. 16/738,516. |
Ando, Tomo, et al. “Iatrogenic ventricular septal defect following transcatheter aortic valve replacement: a systematic review.” Heart, Lung and Circulation 25.10 (2016): 968-974. |
Urena, Marina, et al. “Transseptal transcatheter mitral valve replacement using balloon-expandable transcatheter heart valves: a step-by-step approach.” JACC: Cardiovascular Interventions 10.19 (2017): 1905-1919. |
An English summary of an Official Action dated Mar. 29, 2021, which issued during the prosecution of Chinese Patent Application No. 201780061210.3. |
An International Search Report and a Written Opinion both dated Jan. 28, 2020, which issued during the prosecution of Applicant's PCT/IL2019/051031. |
An International Preliminary Report on Patentability dated Mar. 9, 2021, which issued during the prosecution of Applicant's PCT/IL2019/051031. |
An Office Action dated May 4, 2021, which issued during the prosecution of U.S. Appl. No. 16/636,204. |
Notice of Allowance dated May 17, 2021, which issued during the prosecution of U.S. Appl. No. 16/138,129. |
Notice of Allowance dated Jun. 4, 2021, which issued during the prosecution of U.S. Appl. No. 16/802,353. |
An Office Action dated May 12, 2021, which issued during the prosecution of Canadian Patent Application No. 2,973,940. |
Petition for Inter Partes Review of U.S. Pat. No. 10,702,385—dated Jun. 4, 2021. |
Declaration of Ivan Vesely, Ph.D. In Support of Petition for Inter Partes Review of U.S. Pat. No. 10,702,385—dated Jun. 4, 2021. |
An Office Action dated Dec. 24, 2020, which issued during the prosecution of U.S. Appl. No. 16/144,054. |
An Office Action dated Feb. 2, 2021, which issued during the prosecution of U.S. Appl. No. 16/811,732. |
An Office Action dated Jan. 13, 2021, which issued during the prosecution of European Patent Application No. 15751089.2. |
Maisano, F., et al. “The edge-to-edge technique: a simplified method to correct mitral insufficiency.” European journal of cardio-thoracic surgery 13.3 (1998): 240-246. |
Declaration of Dr. Ivan Vesely, Ph.D. In Support of Petition for Inter Partes Review of U.S. Pat. No. 10,226,341—dated Dec. 17, 2020. |
Petition for Inter Partes Review of U.S. Pat. No. 10,226,341 and Exhibits 1001-1013—dated Dec. 29, 2020. |
An Office Action together with an English summary dated Mar. 3, 2021, which issued during the prosecution of Chinese Patent Application No. 201780047391.4. |
Fucci, C., et al. “Improved results with mitral valve repair using new surgical techniques.” European journal of cardio-thoracic surgery 9.11 (1995): 621-627. |
U.S. Appl. No. 60/128,690, filed Apr. 9, 1999. |
Declaration of Ivan Vesely, Ph.D., in Support of Petition for Inter Partesreview of U.S. Pat. No. 7,563,267—dated May 29, 2019. |
Batista, Randas JV, et al. “Partial left ventriculectomy to treat end-stage heart disease.” the Annals of thoracic surgery 64.3 (1997): 634-638. |
Beall Jr, Arthur C., et al. “Clinical experience with a dacron velour-covered teflon-disc mitral-valve prosthesis.” The Annals of thoracic surgery 5.5 (1968): 402-410. |
Mitral Valve Academic Research Consortium. “Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles A Consensus Document from the Mitral Valve Academic Research Consortium.” Journal of the American College of Cardiology 66.3 (2015): 278-307. |
Kalbacher, D., et al. “1000 MitraClip™ procedures: Lessons learnt from the largest single-centre experience worldwide.” (2019): 3137-3139. |
U.S. Appl. No. 60/613,867, filed Sep. 27, 2004. |
An Office Action dated Nov. 23, 2012, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
An Office Action dated Dec. 31, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
An Office Action dated Feb. 6, 2013, which issued during the prosecution of U.S. Appl. No. 13/412,814. |
Langer F et al., “RING plus STRING: Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation,” J Thorac Cardiovasc Surg 133:247-9, Jan. 2007. |
Langer F et al., “RING+STRING: Successful repair technique for ischemic mitral regurgitation with severe leaflet tethering,” Circulation 120[suppl 1]: S85-S91, Sep. 2009. |
“Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves”, J Webb et al., Circulation. Apr. 2010; 121: 1848-1857. |
Jansen, J., Willeke, S., Reul, H. and Rum, G. (1992), Detachable Shape-Memory Sewing Ring for Heart Valves. Artificial Organs, 16:294-297. 1992 (an abstract). |
Alexander S. Geha, et al., Replacement of degenerated mitral and aortic bioprostheses without explanation Ann Thorac Surg. Jun. 2001; 72:1509-1514. |
An International Search Report and a Written Opinion both dated Oct. 13, 2011 which issued during the prosecution of Applicant's PCT/IL11/00231. |
An Office Action dated Jul. 1, 2016, which issued during the prosecution of U.S. Appl. No. 14/161,921. |
An International Search Report and a Written Opinion both dated Dec. 5, 2011, which issued during the prosecution of Applicant's PCT/IL11/00582. |
An Office Action dated May 29, 2012, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
U.S. Appl. No. 61/555,160, filed Nov. 3, 2011. |
U.S. Appl. No. 61/525,281, filed Aug. 19, 2011. |
U.S. Appl. No. 61/537,276, filed Sep. 21, 2011. |
U.S. Appl. No. 61/515,372, filed Aug. 5, 2011. |
U.S. Appl. No. 61/492,449, filed Jun. 2, 2011. |
U.S. Appl. No. 61/588,892, filed Jan. 20, 2012. |
An International Search Report and a Written Opinion both dated Feb. 6, 2013, which issued during the prosecution of Applicant's PCT/IL12/00292. |
An International Search Report and a Written Opinion both dated Feb. 6, 2013, which issued during the prosecution of Applicant's PCT/IL12/00293. |
An Office Action dated Nov. 28, 2012, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
An Office Action dated Feb. 15, 2013, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
An Office Action dated Feb. 10, 2014, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
An Office Action dated Sep. 19, 2014, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
An International Search Report and a Written Opinion both dated Sep. 4, 2014 which issued during the prosecution of Applicant's PCT/IL2014/050087. |
Invitation to Pay Additional Fees dated Jun. 12, 2014 PCT/IL2014/050087. |
An Office Action dated Jun. 17, 2014, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
An Office Action dated Jul. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
An Office Action dated May 23, 2014, which issued during the prosecution of U.S. Appl. No. 13/412,814. |
Dominique Himbert; Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter approaches and outcomes, 24 pages Oct. 28, 2013. |
An International Search Report and a Written Opinion both dated Mar. 17, 2014 which issued during the prosecution of Applicant's PCT/IL2013/050937. |
An International Preliminary Report on patentabilty dated Dec. 2, 2013, which issued during the prosecution of Applicant's PCT/IL11/00582. |
An Office Action dated Sep. 12, 2013, which issued during the prosecution of U.S. Appl. No. 13/412,814. |
An Office Action dated Aug. 2, 2013, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
An International Preliminary Report on patentabilty dated Sep. 11, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000231. |
An Office Action dated Jul. 2, 2014, which issued during the prosecution of U.S. Appl. No. 13/811,308. |
An Office Action dated Jan. 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/161,921. |
An Office Action dated Jul. 23, 2013, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
An Office Action dated Jul. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
An Office Action dated Nov. 8, 2013, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
An Office Action dated Jun. 4, 2014, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
An Office Action dated Aug. 13, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
An Office Action dated Jul. 2, 2012, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
An Office Action dated Feb. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/811,308. |
An International Preliminary Report on patentabilty dated Feb. 11, 2014, which issued during the prosecution of Applicant's PCT/IL12/00292. |
An International Preliminary Report on patentabilty dated Feb. 11, 2014, which issued during the prosecution of Applicant's PCT/IL12/00293. |
A Notice of Allowance dated Aug. 15, 2014, which issued during the prosecution of U.S. Appl. No. 13/412,814. |
An Office Action dated Aug. 14, 2012, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
U.S. Appl. No. 61/283,819, filed Dec. 8, 2009. |
Notice of Allowance dated Apr. 8, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258. |
U.S. Appl. No. 61/756,034, filed Jan. 24, 2013. |
U.S. Appl. No. 61/756,049, filed Jan. 24, 2013. |
An International Preliminary Report on Patentability dated Jan. 31, 2017, which issued during the prosecution of Applicant's PCT/IL2015/050792. |
An Invitation to pay additional fees dated Mar. 14, 2019, which issued during the prosecution of Applicant's PCT/IL2018/051350. |
Notice of Allowance dated Apr. 20, 2018, which issued during the prosecution of U.S. Appl. No. 15/878,206. |
An Office Action dated Dec. 10, 2015, which issued during the prosecution of U.S. Appl. No. 14/237,258. |
An International Preliminary Report on Patentability dated Jul. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2014/050087. |
An Office Action dated Nov. 27, 2015, which issued during the prosecution of U.S. Appl. No. 14/626,267. |
An Office Action dated Jan. 21, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,264. |
An Office Action dated Jan. 30, 2015, which issued during the prosecution of UK Patent Application No. 1413474.6. |
An International Search Report and a Written Opinion both dated May 30, 2016, which issued during the prosecution of Applicant's PCT/IL2016/050125. |
An Office Action dated Sep. 26, 2016, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
An Office Action dated Jan. 18, 2017, which issued during the prosecution of U.S. Appl. No. 14/626,267. |
An Office Action dated Feb. 7, 2017, which issued during the prosecution of U.S. Appl. No. 14/689,608. |
An Office Action dated Feb. 8, 2017, which issued during the prosecution of UK Patent Application No. 1613219.3. |
An Office Action together dated Feb. 10, 2017, which issued during the prosecution of European Patent Application No. 12821522.5. |
An International Search Report and a Written Opinion both dated Oct. 27, 2015, which issued during the prosecution of Applicant's PCT/IL2015/050792. |
European Search Report dated Feb. 18, 2015, which issued during the prosecution of Applicant's European App No. 12821522.5. |
Saturn Project—a novel solution for transcatheter heart valve replacement specifically designed to address clinical therapeutic needs on mitral valve: Dec. 2016. |
Righini presentation EuroPCR May 2015 (Saturn)—(downloaded from: https://www.pcronline.com/Cases-resourcesimages/Resources/Course-videos-slides/2015/Cardiovascularinnovation-pipeline-Mitral-and-tricuspid-valve-interventions). |
An Advisory Action dated Apr. 2, 2018, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
An Office Action dated Jul. 26, 2018, which issued during the prosecution of U.S. Appl. No. 15/872,501. |
An Office Action dated May 4, 2018, which issued during the prosecution of U.S. Appl. No. 15/872,501. |
An Office Action dated Apr. 20, 2018, which issued during the prosecution of U.S. Appl. No. 15/886,517. |
An Office Action dated Aug. 9, 2018, which issued during the prosecution of U.S. Appl. No. 15/899,858. |
An Office Action dated Aug. 9, 2018, which issued during the prosecution of U.S. Appl. No. 15/902,403. |
An Office Action dated Jun. 28, 2018, which issued during the prosecution of Design U.S. Appl. No. 29/635,658. |
An Office Action dated Jun. 28, 2018, which issued during the prosecution of Design U.S. Appl. No. 29/635,661. |
Georg Lutter, MD, et al; “Percutaneous Valve Replacement: Current State and Future Prospects”, The Annals of Thoracic Surgery ; vol. 78, pp. 2199-2206; Dec. 2004. |
An Office Action dated Jun. 6, 2018, which issued during the prosecution of UK Patent Application No. 1720803.4. |
An International Search Report and a Written Opinion both dated Jun. 20, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050024. |
An Office Action dated Jun. 18, 2018, which issued during the prosecution of UK Patent Application No. 1800399.6. |
An Office Action dated Oct. 23, 2017, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
An Office Action dated Dec. 7, 2017, which issued during the prosecution of U.S. Appl. No. 15/213,791. |
Interview Summary dated Feb. 8, 2018, which issued during the prosecution of U.S. Appl. No. 15/213,791. |
An Office Action dated Feb. 7, 2018, which issued during the prosecution of U.S. Appl. No. 15/197,069. |
An Office Action dated Jun. 15, 2018, which issued during the prosecution of U.S. Appl. No. 15/970,314. |
An Office Action dated Jan. 5, 2018, which issued during the prosecution of U.S. Appl. No. 15/541,783. |
An Office Action dated Feb. 2, 2018, which issued during the prosecution of U.S. Appl. No. 15/329,920. |
An Invitation to pay additional fees dated Jan. 2, 2018, which issued during the prosecution of Applicant's PCT/IL2017/050849. |
An Invitation to pay additional fees dated Sep. 29, 2017, which issued during the prosecution of Applicant's PCT/IL2017/050873. |
European Search Report dated Jun. 29, 2017, which issued during the prosecution of Applicant's European App No. 11809374.9. |
An Invitation to pay additional fees dated Oct. 11, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050725. |
An Office Action dated Dec. 4, 2018, which issued during the prosecution of U.S. Appl. No. 16/045,059. |
An Office Action together with the English translation dated Nov. 5, 2018 which issued during the prosecution of Chinese Patent Application No. 201680008328.5. |
Notice of Allowance dated Sep. 25, 2018, which issued during the prosecution of U.S. Appl. No. 15/188,507. |
European Search Report dated Sep. 26, 2018 which issued during the prosecution of Applicant's European App No. 18186784.7. |
An Office Action dated Jun. 30, 2015, which issued during the prosecution of U.S. Appl. No. 14/522,987. |
Notice of Allowance dated Dec. 13, 2013, which issued during the prosecution of U.S. Appl. No. 13/675,119. |
An International Preliminary Report on Patentability dated Aug. 8, 2017, which issued during the prosecution of Applicant's PCT/IL2016/050125. |
An Office Action dated Jan. 17, 2018, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
An Office Action dated Mar. 25, 2015, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
An Office Action dated Feb. 25, 2016, which issued during the prosecution of U.S. Appl. No. 14/522,987. |
An Office Action dated Apr. 13, 2016, which issued during the prosecution of U.S. Appl. No. 14/626,267. |
An Office Action dated Aug. 28, 2015, which issued during the prosecution of U.S. Appl. No. 14/237,264. |
Maisano (2015) TCR presentation re Cardiovalve. |
Notice of Allowance dated Sep. 29, 2016, which issued during the prosecution of U.S. Appl. No. 14/442,541. |
Notice of Allowance dated May 10, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258. |
Notice of Allowance dated May 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258. |
An International Preliminary Report on Patentability dated May 19, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050937. |
Dusan Pavcnik, MD, PhD2, et al; “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement”, Cardiovascular Radiology. Radiology Apr. 1992, vol. 183, pp. 151-154. |
Notice of Allowance dated Oct. 16, 2013, which issued during the prosecution of U.S. Appl. No. 13/675,119. |
Notice of Allowance dated Feb. 11, 2015, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
Notice of Allowance dated May 5, 2015, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
Notice of Allowance dated Mar. 10, 2015, which issued during the prosecution of U.S. Appl. No. 13/811,308. |
Notice of Allowance dated Jul. 1, 2016, which issued during the prosecution of U.S. Appl. No. 14/442,541. |
An Office Action dated Mar. 25, 2019, which issued during the prosecution of European Patent Application No. 14710060.6. |
An International Search Report and a Written Opinion both dated Nov. 9, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050869. |
An International Search Report and a Written Opinion both dated Dec. 5, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050725. |
An International Search Report and a Written Opinion both dated Apr. 25, 2019, which issued during the prosecution of Applicant's PCT/IL2019/050142. |
An International Preliminary Report on Patentability dated Feb. 12, 2019, which issued during the prosecution of Applicant's PCT/IL2017/050873. |
An Office Action dated Sep. 13, 2019, which issued during the prosecution of U.S. Appl. No. 16/460,313. |
An Office Action dated Nov. 26, 2019, which issued during the prosecution of U.S. Appl. No. 16/532,945. |
An Office Action dated Aug. 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
An Office Action dated Nov. 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/872,501. |
An Office Action dated Jun. 14, 2019, which issued during the prosecution of U.S. Appl. No. 15/703,385. |
An Office Action dated Oct. 4, 2019, which issued during the prosecution of U.S. Appl. No. 16/183,140. |
An Office Action dated Jun. 13, 2019, which issued during the prosecution of U.S. Appl. No. 16/388,038. |
An International Search Report and a Written Opinion both dated Jan. 25, 2019, which issued during the prosecution of Applicant's PCT/IL2018/051122. |
An Office Action dated Oct. 25, 2018, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
An International Search Report and a Written Opinion both dated May 13, 2019, which issued during the prosecution of Applicant's PCT/IL2018/051350. |
An International Preliminary Report on Patentability dated Feb. 5, 2019, which issued during the prosecution of Applicant's PCT/IL2017/050849. |
Notice of Allowance dated Jan. 13, 2020, which issued during the prosecution of U.S. Appl. No. 15/956,956. |
An Office Action dated Mar. 4, 2019, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
An Office Action dated Jan. 9, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920. |
An Office Action dated Jan. 30, 2019, which issued during the prosecution of U.S. Appl. No. 15/872,501. |
An Office Action dated Feb. 5, 2019, which issued during the prosecution of U.S. Appl. No. 15/899,858. |
An Office Action dated May 23, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
An Office Action dated May 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/691,032. |
An Office Action dated Aug. 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,559. |
An Office Action dated Jun. 19, 2019, which issued during the prosecution of U.S. Appl. No. 15/682,789. |
An Office Action dated Jun. 25, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920. |
An Office Action dated May 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/433,547. |
U.S. Appl. No. 62/112,343, filed Feb. 5, 2015. |
An Office Action dated Nov. 16, 2018, which issued during the prosecution of U.S. Appl. No. 16/042,028. |
An Office Action dated May 8, 2018, which issued during the prosecution of U.S. Appl. No. 15/902,403. |
Tchetche, D. and Nicolas M. Van Mieghem: New-generation TAVI devices: description and specifications/EuroIntervention, 2014, No. 10:U90-U100. |
An Office Action dated Jan. 6, 2020, which issued during the prosecution of U.S. Appl. No. 16/660,231. |
An Advisory Action dated Jan. 2, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
Notice of Allowance dated Jul. 19, 2019, which issued during the prosecution of U.S. Appl. No. 15/899,858. |
An Office Action dated Nov. 23, 2018, which issued during the prosecution of U.S. Appl. No. 16/041,208. |
An Office Action dated Jul. 11, 2018, which issued during the prosecution of U.S. Appl. No. 15/978,494. |
Symetis S.A.: “ACURATE neo™ Aortic Bioprosthesis for Implantation using the ACURATE neo™ TA Transapical Delivery System in Patients with Severe Aortic Stenosis,” Clinical Investigation Plan, Protocol No. 2015-01, Vs. No. 2, 2015:1-76: |
An Office Action dated Nov. 26, 2018, which issued during the prosecution of U.S. Appl. No. 16/040,831. |
An Office Action dated Dec. 31, 2019, which issued during the prosecution of U.S. Appl. No. 16/183,140. |
An Office Action dated Jan. 14, 2020, which issued during the prosecution of U.S. Appl. No. 16/284,331. |
European Search Report dated Mar. 5, 2020 which issued during the prosecution of Applicant's European App No. 17752184.6. |
European Search Report dated Mar. 4, 2020 which issued during the prosecution of Applicant's European App No. 16706913.7. |
Notice of Allowance dated Mar. 12, 2020, which issued during the prosecution of U.S. Appl. No. 16/460,313. |
An Office Action dated Jan. 9, 2020, which issued during the prosecution of U.S. Appl. No. 15/600,190. |
An Office Action dated Jan. 3, 2020, which issued during the prosecution of U.S. Appl. No. 16/678,355. |
An Office Action dated Feb. 6, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
An Office Action dated Sep. 6, 2018, which issued during the prosecution of U.S. Appl. No. 15/994,022. |
An Office Action dated Sep. 7, 2018, which issued during the prosecution of U.S. Appl. No. 15/995,725. |
An International Search Report and Written Opinion both dated Mar. 27, 2018, which issued during the prosecution of Applicant's PCT/IL2017/050849. |
Notice of Allowance dated Oct. 5, 2018, which issued during the prosecution of U.S. Appl. No. 15/886,517. |
An Office Action dated Oct. 12, 2018, which issued during the prosecution of U.S. Appl. No. 15/970,314. |
An Office Action dated May 11, 2018, which issued during the prosecution of U.S. Appl. No. 15/899,858. |
An Office Action dated Jul. 26, 2018, which issued during the prosecution of U.S. Appl. No. 15/979,686. |
An Office Action dated Sep. 10, 2018, which issued during the prosecution of U.S. Appl. No. 16/008,618. |
Sündermann, Simon H., et al. “Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design.” European Journal of Cardio-Thoracic Surgery 42.4 (2012): e48-e52. |
Serruys, P. W., Piazza, N., Cribier, A., Webb, J., Laborde, J. C., & de Jaegere, P. (Eds.). (2009). Transcatheter aortic valve implantation: tips and tricks to avoid failure. CRC Press.—Screenshots from Google Books downloaded from: https://books.google.co.il/books?id=FLzLBQAAQBAJ&1pg=PA198&ots=soqWrDH-y_&dq=%20%22Edwards%20SAPIEN%22&lr&pg=PA20#v=onepage&q=%22Edwards%20SAPIEN%22&f=false ; Downloaded on Jun. 18, 2020. |
Notice of Allowance dated May 7, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166. |
Notice of Allowance dated Sep. 10, 2020, which issued during the prosecution of U.S. Appl. No. 15/600,190. |
Notice of Allowance dated Jul. 29, 2020, which issued during the prosecution of U.S. Appl. No. 16/132,937. |
An Office Action dated Aug. 7, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659. |
An International Search Report and a Written Opinion both dated Jun. 24, 2020, which issued during the prosecution of Applicant's PCT/IL2019/051398. |
An Office Action dated Jul. 29, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328. |
Notice of Allowance dated Aug. 26, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328. |
An Office Action dated Jul. 14, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339. |
Notice of Allowance dated Aug. 28, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339. |
An Office Action summarized English translation and Search Report dated Jul. 3, 2020, which issued during the prosecution of Chinese Patent Application No. 201780061210.3. |
Petitioners' Opposition to Patent Owner's Contingent Motion to Amend, Filed Jan. 5, 2022, Edwards Lifesciences Corporation and Edwards Lifesciences LLC v. Cardiovalve Ltd., IPR2021-00383, 32 pages. |
Petitioners' Reply to Patent Owner's Reponse, Filed Jan. 5, 2022, Edwards Lifesciences Corporation and Edwards Lifesciences LLC v. Cardiovalve Ltd., IPR2021-00383, 41 pages. |
Notice of Allowance dated Dec. 6, 2021, issued for U.S. Appl. No. 16/738,516, 30 pages. |
Notice of Allowance dated Dec. 29, 2021, issued for U.S. Appl. No. 17/210,183, 13 pages. |
Notice of Allowance dated Dec. 7, 2021, issued for U.S. Appl. No. 17/394,807, 115 pages. |
Non-Final Office Action dated Jan. 12, 2022, issued for U.S. Appl. No. 17/101,787, 17 pages. |
European Patent Office Communication pursuant to Rule 164(2)(b) and Article 94(3) EPC for App. No. EP18826823.9, dated Nov. 25, 2021, 14 pages. |
European Patent Office Communication pursuant to Article 94(3) EPC for App. No. EP20714289.4, dated Sep. 22, 2021, 5 pages. |
Decision Granting Institution of Inter Partes Review 35 USC §314, dated Dec. 10, 2021, Edwards Lifesciences Corporation and Edwards Lifesciences LLC v. Cardiovalve Ltd., IPR2021-00383, 42 pages. |
English translation of Chinese Office Action issued for CN201880064313.X, dated Jan. 6, 2022, 3 pages. |
An Office Action dated Sep. 15, 2021, which issued during the prosecution of U.S. Appl. No. 16/135,599. |
Notice of Allowance dated Oct. 14, 2021, which issued during the prosecution of U.S. Appl. No. 16/680,739. |
An Office Action dated Oct. 21, 2021, which issued during the prosecution of U.S. Appl. No. 17/335,845. |
European Search Report dated Oct. 11, 2021 which issued during the prosecution of Applicant's European App No. 21176010.3. |
Fann, James I., et al. “Beating heart catheter-based edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response.” Circulation 110.8 (2004): 988-993. |
Feldman, Ted, et al. “Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.” Journal of the American College of Cardiology 54.8 (2009): 686-694. |
IPR2021-00383 Patent Owner's Contingent Motion to Amend Under 37 C.F.R. 42.121 dated Oct. 13, 2021. |
IPR2021-00383 Patent Owner's Response Pursuant to 37 C.F.R. 42.120 dated Oct. 13, 2021. |
IPR2021-00383 Second Declaration of Dr. Michael Sacks dated Oct. 13, 2021. |
An Office Action dated Oct. 21, 2021, which issued during the prosecution of U.S. Appl. No. 17/306,231. |
Maisano, Francesco, et al. “The evolution from surgery to percutaneous mitral valve interventions: the role of the edge-to-edge technique.” Journal of the American College of Cardiology 58.21 (2011): 2174-2182. |
IPR2021-00383 Deposition of Dr. Ivan Vesely, dated Sep. 22, 2021. |
Cardiovalve Exhibit 2009—Percutaneous Mitral Leaflet Repair: MitraClip® Therapy for Mitral Regurgitation (2012). |
Feldman, Ted, et al. “Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial.” Journal of the American College of Cardiology 46.11 (2005): 2134-2140. |
An Office Action summarized English translation and Search Report dated Oct. 8, 2021, which issued during the prosecution of Chinese Patent Application No. 201780061210.3. |
An Office Action dated Nov. 4, 2021, which issued during the prosecution of U.S. Appl. No. 17/366,711. |
An Office Action summarized English translation and Search Report dated Aug. 12, 2021, which issued during the prosecution of Chinese Patent Application No. 201880058940.2. |
European Search Report dated Jun. 10, 2021 which issued during the prosecution of Applicant's European App No. 21157988.3. |
An Invitation to pay additional fees dated May 19, 2021, which issued during the prosecution of Applicant's PCT/IL2021/050132. |
An International Search Report and a Written Opinion both dated Jul. 12, 2021, which issued during the prosecution of Applicant's PCT/IL2021/050132. |
IPR2021-00383 Petitioners' Authorized Reply to Patent Owner's Preliminary Response dated May 27, 2021. |
Exhibit 1014—Transcript of proceedings held May 20, 2021 (Edwards Lifesciences vs. Cardiovalve). |
Exhibit 1015—Facilitate, Meriam-Webster.com, https://www.merriamwebster.com/dictionary/facilitate (visited May 26, 2021). |
Patent Owner's Authorized Surreply to Petitioner's Reply to Patent Owner's Preliminary Response dated Jun. 4, 2021 (Edwards Lifesciences vs. Cardiovalve). |
An Office Action dated Aug. 18, 2021, which issued during the prosecution of U.S. Appl. No. 17/210,183. |
Institution decision dated Jul. 20, 2021 (Edwards Lifesciences vs. Cardiovalve). |
International Search Report and Written Opinion issued in App. No. PCT/IL2021/051433, dated May 3, 2022, 26 pages. |
Number | Date | Country | |
---|---|---|---|
20210322167 A1 | Oct 2021 | US |